###begin article-title 0
###xml 103 104 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
Thyroid Hormone Receptor alpha1 Follows a Cooperative CRM1/Calreticulin-mediated Nuclear Export Pathway*
###end article-title 0
###begin p 1
Both authors contributed equally to this work.
###end p 1
###begin p 2
Current address: Dept. of Functional Genomics, Imaging Core, Genomic Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Dr., San Diego, CA 92121.
###end p 2
###begin p 3
###xml 158 171 158 171 <email xmlns:xlink="http://www.w3.org/1999/xlink">laalli@wm.edu</email>
 To whom correspondence should be addressed: P. O. Box 8795, Millington Hall 116, Williamsburg, VA 23187-8795. Tel.: 757-221-2232; Fax: 757-221-6483; E-mail: laalli@wm.edu.
###end p 3
###begin p 4
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 4
###begin p 5
 applies to Author Choice Articles
###end p 5
###begin p 6
###xml 149 150 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 664 671 644 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 728 736 708 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 795 796 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
The thyroid hormone receptor alpha1 (TRalpha) exhibits a dual role as an activator or repressor of its target genes in response to thyroid hormone (T3). Previously, we have shown that TRalpha, formerly thought to reside solely in the nucleus bound to DNA, actually shuttles rapidly between the nucleus and cytoplasm. An important aspect of the shuttling activity of TRalpha is its ability to exit the nucleus through the nuclear pore complex. TRalpha export is not sensitive to treatment with the CRM1-specific inhibitor leptomycin B (LMB) in heterokaryon assays, suggesting a role for an export receptor other than CRM1. Here, we have used a combined approach of in vivo fluorescence recovery after photobleaching experiments, in vitro permeabilized cell nuclear export assays, and glutathione S-transferase pull-down assays to investigate the export pathway used by TRalpha. We show that, in addition to shuttling in heterokaryons, TRalpha shuttles rapidly in an unfused monokaryon system as well. Furthermore, our data show that TRalpha directly interacts with calreticulin, and point to the intriguing possibility that TRalpha follows a cooperative export pathway in which both calreticulin and CRM1 play a role in facilitating efficient translocation of TRalpha from the nucleus to cytoplasm.
###end p 6
###begin p 7
###xml 49 78 49 78 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 85 101 85 101 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">2R15 DK058028-02</grant-sponsor>
###xml 106 133 106 133 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Science Foundation</grant-sponsor>
###xml 140 151 140 151 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">MCB-0646506</grant-num>
###xml 201 232 201 232 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Howard Hughes Medical Institute</grant-sponsor>
###xml 251 335 251 335 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Undergraduate Biological Sciences Education Program to the College of William &amp; Mary</grant-sponsor>
###xml 516 529 516 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by National Institutes of Health Grant 2R15 DK058028-02 and National Science Foundation Grant MCB-0646506 (to L. A. A.). This work was also supported by a Howard Hughes Medical Institute grant through the Undergraduate Biological Sciences Education Program to the College of William & Mary (to N. G. C., L. E. A., and A. P. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 7
###begin p 8
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 8
###begin p 9
###xml 45 46 37 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 185 186 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 223 224 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 444 445 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 711 712 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 940 941 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
The thyroid hormone receptor alpha1 (TRalpha)4 is a member of the nuclear receptor superfamily of transcription factors. TRalpha acts as an intracellular receptor for thyroid hormone (T3), thereby regulating expression of T3-responsive genes associated with many aspects of development, growth, and metabolism. Among the nuclear receptors, TRalpha is particularly intriguing in that it can modulate transcription whether or not it is bound to T3. Consistent with this dual role as an activator or repressor of transcription, at steady state TRalpha appears to be almost exclusively localized in the nucleus. However, we have shown that the receptor, in fact, shuttles rapidly between the nucleus and cytoplasm (1). Whereas the significance of this nucleocytoplasmic shuttling remains to be precisely characterized, this activity may be related directly to regulation of TRalpha target genes as well as to yet unknown non-genomic functions (2).
###end p 9
###begin p 10
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 403 404 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 406 407 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
Nucleocytoplasmic shuttling occurs as a result of a dynamic balance between the recognition of nuclear localization signals (NLS) and nuclear export signals (NES) by particular import and export factors termed importins and exportins, respectively (3). Most nuclear receptors appear to enter the nucleus via importin alpha/beta recognition and subsequent translocation through the nuclear pore complex (3, 4). Unlike nuclear import, however, the export pathways followed by nuclear receptors remain more elusive.
###end p 10
###begin p 11
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 355 356 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 358 359 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 664 665 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
The most thoroughly studied and well characterized nuclear export pathway involves the exportin CRM1. Many shuttling transcription factors outside of the nuclear receptor superfamily follow a CRM1-dependent mechanism (5, 6). Like other nuclear receptors, however, TRalpha lacks the leucine-rich NES associated with classical CRM1-mediated nuclear export (1, 7). Concordantly, we have shown through interspecies heterokaryon assays that TRalpha nuclear export is not inhibited by leptomycin B (LMB), a potent inhibitor of CRM1 activity. These data clearly indicate that, at least in a heterokaryon system, TRalpha can use a CRM1-independent nuclear export pathway (1).
###end p 11
###begin p 12
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 642 644 642 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
There is compelling evidence that suggests that the Ca2+-binding protein calreticulin (CRT) may play a role in the nuclear export of several nuclear receptors (8-12). For example, the glucocorticoid receptor (GR) undergoes CRT-dependent nuclear export (11, 12) mediated through its highly conserved DNA binding domain (DBD) (8). However, the extent to which CRT functions as an export receptor has remained a subject of debate because its primary role is in the quality control of protein folding in the ER. In addition to this process, CRT has been implicated in an increasing number of critical cellular processes including regulation of Ca2+ homeostasis (13-15), integrin-mediated cell adhesion (16-18), numerous roles in immune response (19, 20), and cardiac muscle development (21-23).
###end p 12
###begin p 13
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
As noted above, a widely used technique to study the subcellular trafficking of nuclear receptors has been the interspecies heterokaryon assay (1, 8, 24-28). Recently, it has been reported that the polyethylene glycol (PEG)-induced fusion of the cytoplasm during this assay disrupts the ER, thereby causing a transient elevation in cytosolic CRT levels as the protein is released from the ER lumen (29). This fusion process may alter the export kinetics of some shuttling proteins. For example, in contrast to the rapid shuttling of GR observed in heterokaryon assays (8, 25), GR shuttling was found to occur only slowly over a period of hours during fluorescence recovery after photobleaching (FRAP) experiments in monokaryons (29). Moreover, in contrast to heterokaryon fusion experiments in which GR shuttling was shown to be CRT-dependent (8), slow GR recovery in experiments other than heterokaryon fusions was shown to occur in a CRT-independent manner (29). Given these results, the question has arisen as to whether CRT-dependent nuclear export occurs under physiological conditions or merely in response to exogenous environmental stresses such as cell fusion.
###end p 13
###begin p 14
###xml 226 233 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 252 260 248 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 359 366 355 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 371 379 367 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
With these data in mind we sought to ascertain whether TRalpha shuttles under physiological conditions and, if so, whether it follows a CRT or CRM1-dependent nuclear export pathway. To this end, we used a combined approach of in vivo FRAP experiments, in vitro digitonin-permeabilized cell nuclear export assays, and GST pull-down assays. Taken together, our in vivo and in vitro data point to the intriguing possibility that TRalpha uses an export pathway in which CRT binds directly to TRalpha and, thereby, promotes a cooperative interaction in which both CRT and CRM1 play a role in mediating rapid, efficient translocation of TRalpha from the nucleus to cytoplasm.
###end p 14
###begin title 15
EXPERIMENTAL PROCEDURES
###end title 15
###begin p 16
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmids</italic>
###xml 331 332 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 98 119 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 211 214 <span type="species:ncbi:10116">rat</span>
Plasmids-The plasmid pGFP-TRalpha encodes a functional GFP-TRalpha fusion protein expressed under human cytomegalovirus promoter control. This plasmid was constructed by subcloning the PCR product of rTRalpha1 (rat) cDNA into the enhanced GFP expression plasmid pEGFP-C1 (Clontech Laboratories, Inc.) using SacI and BamHI enzymes (1).
###end p 16
###begin p 17
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 237 252 <span type="species:ncbi:10633">simian virus 40</span>
###xml 254 258 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The plasmid pNES-GFP-GST-NLS was a gift from R. Hache (University of Ottowa, Ottowa, Ontario) and contains the classic HIV-1 Rev NES sequence cloned into the ApaI site of pGFP-GST-NLS, a plasmid that includes the sequence of the classic simian virus 40 (SV40) large T antigen NLS at the 3' end (described further in Ref. 29). The plasmid pGEX-CRTwt was a gift from B. Paschal and encodes full-length calreticulin subcloned into the pGEX-KG vector for overexpression in bacteria (12). The plasmid pET-His-CRM1-H was a gift from J. Kjems and encodes His-CRM1 for overexpression in bacteria (28).
###end p 17
###begin p 18
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture</italic>
###xml 202 203 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 227 230 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 230 233 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 244 247 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 247 250 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 297 299 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 86 92 <span type="species:ncbi:9913">bovine</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 397 401 <span type="species:ncbi:9913">calf</span>
Cell Culture-HeLa cells (ATCC CCL-2) were cultured in MEM supplemented with 10% fetal bovine serum (Invitrogen) containing penicillin (100 units/ml)/streptomycin (100 mug/ml), at 37 degreesC under 5% CO2 and 98% humidity. K41 (crt-/-) and K42 (crt+/+) cells were a generous gift from M. Michalak (30). These mouse embryonic fibroblasts were cultured in Dulbecco's modified Eagle's medium with 10% calf serum under similar conditions. Cells were grown to 70-90% confluency.
###end p 18
###begin p 19
###xml 0 44 0 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Transient Transfection and Live Cell Imaging</italic>
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
Transient Transfection and Live Cell Imaging-For transient transfections, cells were seeded at 4-7 x 105 cells per 60-mm vented dish (Nunc, Rochester, NY) onto 5-cm coverslips. Twenty-four h after seeding, cells at 40-60% confluency were transfected with 4 mug of plasmid DNA and 20 mul of Lipofectamine Reagent (Invitrogen) in Opti-MEM I Reduced Serum Medium (Invitrogen) according to the manufacturer's protocol. Reduced serum medium was replaced with complete medium 16-18 h post-transfection.
###end p 19
###begin p 20
###xml 299 300 297 298 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 653 654 649 650 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
After transfection, cells were used for microscopy within 48 h. Prior to mounting in an enclosed perfusion chamber (Bioptechs, Butler, PA), coverslips were incubated in 2 ml of complete media containing 100 mug/ml cycloheximide (Sigma), penicillin (100 units/ml)/streptomycin (100 mug/ml), and 2-4 nm LMB (Sigma) or with vehicle (0.1% methanol) for 30 min. Coverslips were then washed with 2 ml of Dulbecco's phosphate-buffered saline (PBS) and mounted. For the duration of each experiment, cells were incubated in MEM or Dulbecco's modified Eagle's medium containing 50 mug/ml cycloheximide, penicillin (50 units/ml)/streptomycin (50 mug/ml), and 2-4 nm LMB or vehicle (0.1% methanol).
###end p 20
###begin p 21
Images were collected from an inverted Nikon ECLIPSE TE 2000-E fluorescence microscope equipped with a Radiance 2100 laser scanning unit using a x60 1.2 NA water objective (Nikon). The 488-nm line of a krypton-argon laser with a bandpass 515/30 nm emission filter was used for GFP detection and images were obtained using the time course module of Laser Sharp 2000 (Zeiss, Thornwood, NY).
###end p 21
###begin p 22
FRAP was recorded to analyze shuttling of proteins between nuclei within monokaryons. All FRAP experiments were performed in a temperature-controlled setting using a FCS2 live-cell chamber heating system and objective heater system (Bioptechs) to maintain 37 degreesC. After the appropriate temperature was reached, an initial image was recorded from an area containing a multinucleated GFP-expressing cell using 2-8% laser power from the 488 nm line of a krypton-argon laser. One nucleus within the monokaryon was exposed at 50% laser power for two cycles using the same laser. After this bleaching exposure, sequential images were taken every 5 min for 11 cycles. To minimize undesired photobleaching, low laser intensities of 2-8% were again used for post-bleach images. For quantitative analysis of digitized images, fluorescence intensity values were generated using ImageJ (NIH). Bleached and unbleached nuclei were each considered as independent regions of interest. In addition, these values took into account the background brightness levels during each experiment. Intensity values were subsequently normalized so that the total fluorescence within each monokaryon after bleaching was equal to 1. Graphs were generated using Microsoft Excel.
###end p 22
###begin p 23
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Heterokaryon Assay</italic>
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 257 260 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 260 263 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 532 533 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 412 418 <span type="species:ncbi:9913">bovine</span>
Heterokaryon Assay-For the preparation of heterokaryons, crt-/- cells (K42) were seeded at 2-2.5 x 105 cells/well onto coverslips in 6-well dishes. Cells were then transfected with a GFP-TRalpha expression vector. Twenty-four hours post-transfection of the crt-/- cells, human HeLa cells were trypsinized and resuspended in heterokaryon growth medium containing 70% Dulbecco's modified Eagle's medium, 10% fetal bovine serum, and 20% sterile distilled water. The resuspended cells were then plated on the same coverslips at 5-6 x 105 cells/well. The cells were then incubated for 2.5 h in the presence of cycloheximide at 50 mug/ml followed by 30 min in media with cycloheximide at 100 mug/ml at 37 degreesC to allow adherence. Subsequently, the cells were rinsed with Dulbecco's PBS. For cell fusion, coverslips were placed on 100-mul drops of warm 50% polyethylene glycol 1500 (Roche Applied Science, Indianapolis, IN) and incubated for exactly 2 min. Each coverslip was then rinsed with Dulbecco's PBS and incubated for 2 h at 37degreesC in heterokaryon growth media containing 100 mug/ml cycloheximide.
###end p 23
###begin p 24
###xml 895 896 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 312 316 <span type="species:ncbi:9925">goat</span>
###xml 436 440 <span type="species:ncbi:9925">goat</span>
Following incubation, the cells were rinsed with Dulbecco's PBS and then fixed for 10 min in 3.7% formaldehyde. After three 5-min washes with Dulbecco's PBS, the cells were permeabilized using 0.2% Triton X-100. Following three 5-min washes with Dulbecco's PBS the cells were incubated in 200 mul of 1.5% normal goat serum for 20 min. The cells were then washed with Dulbecco's PBS and incubated for an additional 20 min in 1.5% normal goat serum containing 0.5 units/ml rhodamine-phalloidin (Molecular Probes, Eugene, OR) to visualize actin. Following a wash in Dulbecco's PBS, the cells were then incubated for 10 min in Dulbecco's PBS containing 10 mug/ml Hoechst 33258 (Sigma) to visualize DNA. Finally, the coverslips were mounted on slides using GelMount mounting media (Biomeda, Foster City, CA). Slides were examined by fluorescence microscopy and images were obtained with a CoolSNAP HQ2 CCD camera (Photometrics, Tucson, AZ) and NIS-Elements software (Nikon).
###end p 24
###begin p 25
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibody Staining</italic>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 183 184 183 184 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 333 337 <span type="species:ncbi:9925">goat</span>
###xml 470 476 <span type="species:ncbi:9986">rabbit</span>
###xml 693 697 <span type="species:ncbi:9925">goat</span>
###xml 703 709 <span type="species:ncbi:9986">rabbit</span>
Antibody Staining-Cells were grown to 80-90% confluency and plated at 2 x 105 cells/well onto coverslips in six-well dishes (Nunc). 24 h post-plating, coverslips were incubated in 2 nm LMB or 0.1% methanol for 5 h. The cells were then fixed and permeabilized. After fixation and permeabilization, cells were incubated in 1.5% normal goat serum in Dulbecco's PBS for 30 min. The cells were then washed in Dulbecco's PBS and probed for 1 h in blocking solution containing rabbit polyclonal anti-CRT antibodies (Stressgen, Ann Arbor, MI) diluted to 1:1000. Cells were then washed in Dulbecco's PBS three times for 5 min each prior to incubation for 1 h with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) diluted to 1:600. After incubation the cells were washed in Dulbecco's PBS and mounted using GelMount containing 4',6-diamidino-2'-phenylindole dihydrochloride (Sigma) (0.5 mug/ml). CRT staining was visualized by fluorescence microscopy.
###end p 25
###begin p 26
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nuclear Extractions</italic>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 206 207 206 207 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 227 228 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 238 239 238 239 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 279 280 279 280 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 323 324 323 324 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 847 848 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1272 1273 1259 1260 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1293 1294 1280 1281 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1305 1306 1292 1293 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1340 1341 1327 1328 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1376 1377 1363 1364 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Nuclear Extractions-Cells were plated at 1-2 x 107 and grown for 24 h to confluence in 100-mm vented dishes. Cells were rinsed 3 times in Dulbecco's PBS and nuclei lysed in 1 ml of Cell Lysis Solution (10 mm Hepes, pH 7.9, 10 mm KCl, 10 mm EDTA pH 8.0, 0.4% IGEPAL (Sigma), 0.5 mm phenylmethylsulfonyl fluoride (Roche), 1 mm dithiothreitol (dithiothreitol) (Omnipur, Gibbstown, NJ), Complete Mini EDTA-free Protease Inhibitor Mixture Tablet (1 tablet/10 ml) (Roche) for 10 min at 4 degreesC. The lysed cells were scraped and sheared by four passages through a 21-gauge needle. The quality and purity of the nuclei were monitored by differential interference contrast (DIC) microscopy at x600; shearing was repeated until >95% of nuclei were visibly free from ER and other cytoplasmic contamination. Nuclei were pelleted by a 5-s pulse spin (200 x g) at 4 degreesC in a microcentrifuge. The cytoplasmic fraction was collected and the purified nuclei were washed twice with 1 ml of extraction solution. A small fraction of the resuspended nuclei from the last wash was observed by DIC to confirm that the nuclei had remained intact and were free from ER and other cytoplasmic debris. The nuclear proteins were then extracted with 100 mul of Nuclear Extraction Solution (20 mm Hepes, pH 7.9, 0.4 m NaCl, 10 mm EDTA, pH 8.0, 10% glycerol, 0.5 mm phenylmethylsulfonyl fluoride, 1 mm dithiothreitol, Complete Mini EDTA-free Protease Inhibitor Mixture Tablets (1 tablet/10 ml)). Proteins from nuclear and cytoplasmic fractions were then analyzed by Western blot.
###end p 26
###begin p 27
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blotting</italic>
###xml 289 295 <span type="species:ncbi:9986">rabbit</span>
###xml 627 633 <span type="species:ncbi:9913">bovine</span>
###xml 805 811 <span type="species:ncbi:9986">rabbit</span>
###xml 869 875 <span type="species:ncbi:9986">rabbit</span>
###xml 1280 1291 <span type="species:ncbi:3704">horseradish</span>
###xml 1314 1318 <span type="species:ncbi:9925">goat</span>
###xml 1324 1330 <span type="species:ncbi:9986">rabbit</span>
Western Blotting-The approximate concentration of total protein in nuclear and cytoplasmic samples was determined by absorption at 280 nm. For cytoplasmic and whole cell extract, 40 mug of protein were analyzed per lane, 40-60 mug per lane were used for nuclear extracts, and 0.5-2 mul of rabbit reticulocyte lysate (RRL) (Promega, Madison, WI) were analyzed. The samples were separated by 8% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Amersham Biosciences) by semi-dry electroblotting (Bio-Rad). The membranes were incubated overnight in the presence of blocking solution (Tris-buffered saline (TBS), 1% bovine serum albumin, 0.1% Tween 20). After six washes with TBS, the membranes were incubated with the primary antibodies for 1 h. For the detection of CRT and beta-tubulin both rabbit polyclonal anti-CRT antibodies (SPA-600D, Stressgen) and rabbit polyclonal anti-beta-tubulin antibodies (Affinity Bioreagents, Golden, CO) were mixed together in blocking solution at 1:20,000 and 1:200, respectively. For the detection of CRM1 and CRT, Western blots were incubated separately with anti-CRM1 (Affinity Bioreagents) or anti-CRT (Stressgen) antibodies at 1:200 or 1:20,000, respectively. The blots were then washed six times with TBS and incubated with a horseradish peroxidase-conjugated goat anti-rabbit IgG (GE Healthcare) at 1:30,000 for 1 h in blocking solution. Following this incubation, the blots were washed again six times and incubated with ECL-Plus detection reagent (GE Healthcare). Subsequently, the blots were analyzed using a Storm 860 Molecular Imager scanner (GE Healthcare) and ImageJ (NIH).
###end p 27
###begin p 28
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Protein Overexpression</italic>
###xml 99 115 99 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 209 212 209 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 273 274 267 268 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 290 291 281 282 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 429 430 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 99 115 <span type="species:ncbi:562">Escherichia coli</span>
Protein Overexpression-Plasmids coding for the protein of interest were transformed into competent Escherichia coli (BL21 DE3-RIl) (Stratagene, La Jolla, CA), per the manufacturer's protocol, and grown to an A600 of 0.6-0.8 at 37 degreesC. Expression was induced with 0.5 mm isopropyl beta-d-thiogalactoside (Fisher Scientific, Pittsburgh, PA) and grown 3-5 h at 30 degreesC. Post-expression cultures were centrifuged at 1,700 x g for 15 min at 4 degreesC; bacterial pellets were stored at -80 degreesC prior to protein purification.
###end p 28
###begin p 29
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST Protein Purification</italic>
###xml 169 170 167 168 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 479 480 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 711 712 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 817 818 796 797 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 830 831 809 810 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 841 842 820 821 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 845 846 824 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 849 850 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 857 858 836 837 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 861 862 840 841 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 864 865 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1024 1025 1001 1002 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1148 1149 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
GST Protein Purification-Bacterial pellets were resuspended in 10 ml of B-PER(R) Bacterial Protein Extraction Reagent (Pierce), 1 ml of 5.0 mg/ml lysozyme (Fisher), 10 mm Tris, pH 8.0, and one Complete Mini EDTA-free Protease Inhibitor Mixture tablet (Roche). Resuspended pellets were incubated on ice for 30 min. The pellets were subsequently sonicated (Sonic Dismembrator model 100; Fisher) on ice to fully lyse the bacteria. The lysed mixture was then centrifuged at 17,950 x g for 15 min at 4 degreesC, and the supernatant was applied to 200 mul of 50% glutathione-Sepharose 4B resin (GE Healthcare). Samples were incubated for 60 min at 4 degreesC with gentle rotation, then centrifuged for 5 min at 500 x g at 4 degreesC to pellet the resin. The resin pellet was washed 3 times with 10 ml of ice-cold PBS (140 mm NaCl, 2.7 mm KCl, 10 mm Na2HPO4, 1.8 mm KH2PO4, pH 7.3) and then transferred to a Microfilter Spin Column (Pierce) and washed twice with 600 mul of ice-cold PBS. 100 mul of Glutathione Elution Buffer (10 mm glutathione) was added to the column, incubated at room temperature for 2-4 min with agitation, then centrifuged at 700 x g for 30 s at 4 degreesC to collect eluted protein. The elution step was repeated 3 times. The eluted fractions were pooled and dialyzed (Slide-A-Lyser(R) Mini Dialysis Units, 7000 MWCO, Pierce) against Dulbecco's PBS overnight at 4 degreesC. Protein samples were then concentrated using Micron Ultracel YM-30 Centrifugal Filter Devices (Millipore, Bedford, MA). Concentrated protein samples were analyzed by SDS-PAGE and protein concentration estimated using a Nano-Drop(R) ND-1000 full-spectrum UV-Visual Spectrophotometer. Samples were stored at -80 degreesC.
###end p 29
###begin p 30
###xml 0 40 0 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Permeabilized Cell Nuclear Export Assays</italic>
###xml 181 182 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 553 554 542 543 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 575 576 564 565 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 586 587 575 576 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 598 599 587 588 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 607 608 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 613 614 602 603 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 624 625 613 614 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 645 646 634 635 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1068 1069 1055 1056 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1131 1132 1118 1119 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1143 1144 1130 1131 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1173 1174 1160 1161 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 457 463 <span type="species:ncbi:9913">bovine</span>
Permeabilized Cell Nuclear Export Assays-HeLa cells were seeded on 22-mm Coverslips for Cell Growthtrade mark (Fisher) in 6-well culture dishes (Nunc) at a concentration of 2-3 x 105 cells per well. 24 h post-seeding each well was transiently transfected with 2 mug of plasmid DNA and 10 mul of Lipofectamine reagent (Invitrogen) in Opti-MEM I reduced serum medium, and incubated 12-16 h. After 12-16 h Opti-MEM I was replaced with MEM containing 10% fetal bovine serum. After 4 h cells were washed 3 times with 2 ml/well of ice-cold export buffer (20 mm Hepes, pH 7.3, 110 mm KOAc, 5 mm NaOAc, 2 mm Mg(OAc)2, 1 mm EGTA, 2 mm dithiothreitol, 1 mm phenylmethylsulfonyl fluoride, Complete Mini EDTA-free Protease Inhibitor Mixture tablet (1 tablet/10 ml) (Roche), then permeabilized with digitonin (50 mug/ml; Calbiochem, San Diego, CA) in export buffer for 4.5 min. Subsequently, cells were rinsed with 2 ml/well of ice-cold export buffer for 10 min. Coverslips were then inverted over 50-mul drops of export reaction mixture (energy regeneration system composed of 5 mm creatine phosphate, 20 units/ml creatine phosphokinase, 0.5 mm ATP, 0.5 mm GTP, 5x export buffer, 670 nm GST-CRT, and 25 mul of RRL) on parafilm in a moist chamber for 30 min at 30 degreesC. Cells were then fixed in 3.7% formaldehyde (Fisher) for 10 min followed by a 5-min rinse with export buffer. Coverslips were subsequently mounted on slides with 8 mul of GelMount with 4',6-diamidino-2'-phenylindole (0.5 mug/ml), and viewed by fluorescence microscopy.
###end p 30
###begin p 31
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST Pull-down Assays</italic>
###xml 249 250 249 250 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 266 267 266 267 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1090 1091 1045 1046 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1290 1294 <span type="species:ncbi:185542">Mate</span>
GST Pull-down Assays-Pull-down assays using GST-CRT were performed using the ProFound Pull-down GST Protein: Protein Interaction Kit (Pierce), and modified amounts of GST resin/protein. GST resin was equilibrated with five 0.5-ml washes of TBS (25 mm Tris.HCl, 0.15 m NaCl, pH 7.2):Pro-Found Lysis Buffer (1:1). Bait protein immobilization was performed at 4 degreesC for 30 min with gentle rocking. For GST-CRT/His-CRM1 interactions, 50 mul of 50% GST resin was used to bind 40 mug of GST-CRT bait protein. For GST-CRT/His-TRalpha and GST-CRT/His-TRalpha/His-CRM1 interactions, 5 mul of 50% GST resin was used to bind 4 and 7 mug of GST-CRT bait protein, respectively. Bound bait protein was washed 5 times with 0.5 ml of TBS:ProFound Lysis Buffer (1:1). Prey protein capture was performed at 4 degreesC for 1 h with gentle rocking. For GST-CRT:CRM1, GST-CRT:TRalpha binding, and GST-CRT:TRalpha: CRM1, 40 mug of His-CRM1, 2 mug of His-TRalpha (Active Motif, Carlsbad CA), and 3.5 mug of His-TRalpha, 3.5 mug of His-CRM1 prey were used. Bait-Prey elution was performed with 50 mul of 100 mm Glutathione Elution Buffer for GST-CRT/CRM1 interactions, and 12.5 mul for GST-CRT/TRalpha and GST-CRT/TRalpha/CRM1 interactions. All elutions were analyzed via SDS-PAGE using an 8-16% precast Gene Mate Express Gel (ISC BioExpress, Kaysville, UT). Gels were stained with SimplyBluetrade mark SafeStain (Invitrogen) and imaged using a Bio-Rad Gel Doc XR documentation system with Quantity One analysis software (version 4.6.1).
###end p 31
###begin p 32
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coimmunoprecipitation Assays</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 311 312 307 308 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Coimmunoprecipitation Assays-For coimmunoprecipitation assays, HeLa, crt-/-, and crt+/+ cells were transfected with expression vectors for GFP-TRalpha, or GFP alone as a control, in 100-mm plates using Lipofectamine 2000 (Invitrogen). 20 h post-transfection, the medium was replaced with medium containing 2-4 nm LMB or vehicle (0.1% methanol). Cells were lysed 5 h later and nuclear extracts were prepared using a Nuclear Extract Kit (Active Motif) according to the manufacturer's instructions. Nuclear extracts were incubated with anti-CRT antibodies bound to Dynal Dynabeads(R) Protein G (Invitrogen) for 2 h at 4degreesC. The immunoprecipitated material was captured on a DynaMagtrade mark-2 magnetic particle concentrator, washed, and eluted in SDS-PAGE sample buffer. Samples of immunosupernatants and immunoprecipitated material were separated by 8% SDS-PAGE. Replicate Western blots were prepared and probed with anti-CRT, anti-CRM1, and anti-GFP (Santa Cruz Biotechnology Inc.) antibodies, followed by chemiluminescent detection.
###end p 32
###begin title 33
RESULTS
###end title 33
###begin p 34
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TR</italic>
###xml 8 59 4 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shuttling in Living Cells Is Leptomycin B Sensitive</italic>
###xml 349 350 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 457 461 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 514 518 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 863 865 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 462 467 <span type="species:ncbi:10090">mouse</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
TRalpha Shuttling in Living Cells Is Leptomycin B Sensitive-The thyroid hormone receptor is a dynamic protein that shuttles rapidly between the nucleus and cytoplasm in heterokaryon assays. This shuttling is not blocked by LMB in heterokaryons, indicating that TRalpha is exiting the nucleus by a CRM1-independent pathway in the heterokaryon assay (1). The heterokaryon assay involves PEG-induced fusion of the cytosols of transfected cells of one species (e.g. mouse) with untransfected cells of another species (e.g. human). Movement of the protein of interest can then be monitored from the nuclei of transfected cells into the shared cytosol of the fused cells and, subsequently, into the nuclei of the opposing species. The recent finding that PEG-induced cell fusion causes changes in the cellular environment including a transient elevation in CRT levels (29) has called into question the validity and interpretation of previous heterokaryon experiments.
###end p 34
###begin p 35
###xml 912 918 904 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1393 1396 1381 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 1396 1399 1384 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1524 1526 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1597 1598 1581 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1591 1598 1575 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1604 1607 1588 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 1607 1610 1591 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1630 1631 1614 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1624 1631 1608 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1737 1738 1717 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 1372 1377 <span type="species:ncbi:9606">human</span>
###xml 1387 1392 <span type="species:ncbi:10090">mouse</span>
We first sought to determine whether TRalpha shuttles under physiological conditions by performing experiments in living cells, independent of heterokaryon formation. To maintain physiological conditions, we used a FRAP assay in multinucleate live cells (monokaryons) to monitor the movement of GFP-TRalpha from unbleached to bleached nuclei. Unlike in heterokaryons, a monokaryon system does not require cell fusion or other manipulation that would compromise the integrity of the ER and thus, presumably, maintains low levels of cytosolic CRT. Transfected monokaryons were selected and one nucleus within these cells was exposed to intense laser illumination. This exposure resulted in loss of fluorescence within the selected nucleus due to irreversible photobleaching of the GFP fluorophore. The initial bleaching did not, however, result in loss of fluorescence to neighboring nuclei within the same cells (Fig. 1). A series of images was taken for each individual experiment in which fluorescence recovery to bleached nuclei was measured and compared with the concomitant decrease in intensity within unbleached nuclei. Through image analysis and plotting of these fluorescence intensity data, we were able to determine the relative degree of nucleocytoplasmic shuttling within particular cell types and treatments. Specifically, we assayed for TRalpha shuttling in human HeLa and mouse crt+/+ cell lines, both of which express CRT. We show that, in contrast to the slow nuclear export observed for GR in COS-7 cells (29), TRalpha in fact shuttles rapidly between nuclei in both HeLa (Fig. 1A) and crt+/+ monokaryons (Fig. 1B). These data are in close agreement with those observed for TRalpha shuttling kinetics in heterokaryons (1), and suggest that TRalpha may play an as yet unknown role in cytosolic signaling pathways. After confirming that TRalpha rapidly shuttles between nuclei in these cells, we sought to determine whether TRalpha follows a CRM1 or CRT-dependent nuclear export pathway in live, unfused cells.
###end p 35
###begin p 36
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 11 9 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TR</bold>
###xml 17 97 13 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.</bold>
###xml 97 98 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 226 227 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 234 250 226 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White arrowheads</italic>
###xml 342 343 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 530 543 518 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Black squares</italic>
###xml 611 624 599 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open diamonds</italic>
###xml 772 782 760 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 795 796 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 804 805 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 812 815 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 815 818 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 830 831 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 844 845 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 858 861 844 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 9 870 9 855 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><bold>TR</bold>&#945; <bold>shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.</bold><italic>A</italic>, HeLa cells were transfected with a GFP-TR&#945; expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (<italic>n</italic> = 7). <italic>White arrowheads</italic> indicate photobleached nuclei. Parallel experiments were performed in the presence of LMB (<italic>n</italic> = 6) to block CRM1-mediated nuclear export and DIC images were taken to delineate cell borders. Fluorescence recovery graphs indicating relative shuttling of GFP-TR&#945; were generated. <italic>Black squares</italic> indicate relative fluorescence levels within unbleached nuclei and <italic>open diamonds</italic> represent levels within bleached nuclei. Any apparent change in nucleus morphology is a result of cell movement over the course of the experiment. <italic>Error bars</italic>, &#177; 1 S.E. <italic>B</italic>, as in <italic>A</italic> using <italic>crt</italic><sup>+/+</sup> cell line (<italic>n</italic> = 10, -LMB; <italic>n</italic> = 6, +LMB). <italic>Bar</italic>, 10 &#956;m.</p>
###xml 9 870 9 855 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><bold>TR</bold>&#945; <bold>shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.</bold><italic>A</italic>, HeLa cells were transfected with a GFP-TR&#945; expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (<italic>n</italic> = 7). <italic>White arrowheads</italic> indicate photobleached nuclei. Parallel experiments were performed in the presence of LMB (<italic>n</italic> = 6) to block CRM1-mediated nuclear export and DIC images were taken to delineate cell borders. Fluorescence recovery graphs indicating relative shuttling of GFP-TR&#945; were generated. <italic>Black squares</italic> indicate relative fluorescence levels within unbleached nuclei and <italic>open diamonds</italic> represent levels within bleached nuclei. Any apparent change in nucleus morphology is a result of cell movement over the course of the experiment. <italic>Error bars</italic>, &#177; 1 S.E. <italic>B</italic>, as in <italic>A</italic> using <italic>crt</italic><sup>+/+</sup> cell line (<italic>n</italic> = 10, -LMB; <italic>n</italic> = 6, +LMB). <italic>Bar</italic>, 10 &#956;m.</p></caption>
###xml 870 870 855 855 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330001"/>
###xml 0 870 0 855 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="37"><bold>TR</bold>&#945; <bold>shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.</bold><italic>A</italic>, HeLa cells were transfected with a GFP-TR&#945; expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (<italic>n</italic> = 7). <italic>White arrowheads</italic> indicate photobleached nuclei. Parallel experiments were performed in the presence of LMB (<italic>n</italic> = 6) to block CRM1-mediated nuclear export and DIC images were taken to delineate cell borders. Fluorescence recovery graphs indicating relative shuttling of GFP-TR&#945; were generated. <italic>Black squares</italic> indicate relative fluorescence levels within unbleached nuclei and <italic>open diamonds</italic> represent levels within bleached nuclei. Any apparent change in nucleus morphology is a result of cell movement over the course of the experiment. <italic>Error bars</italic>, &#177; 1 S.E. <italic>B</italic>, as in <italic>A</italic> using <italic>crt</italic><sup>+/+</sup> cell line (<italic>n</italic> = 10, -LMB; <italic>n</italic> = 6, +LMB). <italic>Bar</italic>, 10 &#956;m.</p></caption><graphic xlink:href="zbc0410850330001"/></fig>
FIGURE 1.TRalpha shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.A, HeLa cells were transfected with a GFP-TRalpha expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (n = 7). White arrowheads indicate photobleached nuclei. Parallel experiments were performed in the presence of LMB (n = 6) to block CRM1-mediated nuclear export and DIC images were taken to delineate cell borders. Fluorescence recovery graphs indicating relative shuttling of GFP-TRalpha were generated. Black squares indicate relative fluorescence levels within unbleached nuclei and open diamonds represent levels within bleached nuclei. Any apparent change in nucleus morphology is a result of cell movement over the course of the experiment. Error bars, +/- 1 S.E. B, as in A using crt+/+ cell line (n = 10, -LMB; n = 6, +LMB). Bar, 10 mum.
###end p 36
###begin p 37
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TR</bold>
###xml 8 88 4 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.</bold>
###xml 88 89 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 217 218 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 225 241 217 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White arrowheads</italic>
###xml 333 334 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 521 534 509 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Black squares</italic>
###xml 602 615 590 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open diamonds</italic>
###xml 763 773 751 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 786 787 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 795 796 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 803 806 789 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 806 809 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 821 822 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 835 836 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 849 852 835 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
TRalpha shuttling is inhibited by treatment with LMB in live monokaryons expressing CRT.A, HeLa cells were transfected with a GFP-TRalpha expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (n = 7). White arrowheads indicate photobleached nuclei. Parallel experiments were performed in the presence of LMB (n = 6) to block CRM1-mediated nuclear export and DIC images were taken to delineate cell borders. Fluorescence recovery graphs indicating relative shuttling of GFP-TRalpha were generated. Black squares indicate relative fluorescence levels within unbleached nuclei and open diamonds represent levels within bleached nuclei. Any apparent change in nucleus morphology is a result of cell movement over the course of the experiment. Error bars, +/- 1 S.E. B, as in A using crt+/+ cell line (n = 10, -LMB; n = 6, +LMB). Bar, 10 mum.
###end p 37
###begin p 38
###xml 124 125 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 219 222 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 222 225 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 395 401 383 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 536 537 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 692 695 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 695 698 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 733 739 717 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1036 1039 1012 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 1039 1042 1015 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1059 1065 1035 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
Based on our previous data showing that TRalpha nucleocytoplasmic shuttling is not blocked by LMB in a heterokaryon system (1), we predicted that we would observe rapid shuttling of TRalpha between nuclei when HeLa and crt+/+ monokaryons were treated with LMB. Surprisingly, we saw only slow recovery of TRalpha within photobleached monokaryon nuclei of both cell types during FRAP experiments (Fig. 1). In contrast to previous data for heterokaryons in which near complete equilibration between nuclei was seen over the course of 1 h (1), recovery of fluorescence to bleached nuclei within live monokaryons treated with LMB was limited to only 22% (+/-3%) for HeLa cells and 14% (+/-2%) for crt+/+ cells over a similar time course (Fig. 1). These results are in sharp contrast to parallel FRAP experiments performed in the absence of LMB, during which TRalpha shuttling was much more rapid. In these experiments recovery to the bleached nuclei was measured at 56% (+/-4%) equilibration for HeLa cells and 88% (+/-2%) equilibration for crt+/+ cells over 1 h (Fig. 1). To graphically illustrate the sensitivity of TRalpha nucleocytoplasmic shuttling to LMB, mean brightness values for photobleached and unbleached nuclei were plotted as a function of time post-bleach. Fluorescence intensity was normalized so that the overall fluorescence of bleached and unbleached nuclei was equal to 1.0 (arbitrary units). After normalization, convergence of the representative curves for bleached nuclei and unbleached nuclei toward one another represents the degree of fluorescence equilibration between these compartments. When one bleached and one unbleached nucleus are present, complete equilibration occurs at 0.5 fluorescence units.
###end p 38
###begin p 39
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 11 9 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TR</bold>
###xml 17 49 13 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">requires CRT for nuclear export.</bold>
###xml 49 52 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 52 55 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 177 178 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 185 201 177 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White arrowheads</italic>
###xml 370 373 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 9 382 9 369 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><bold>TR</bold>&#945; <bold>requires CRT for nuclear export.</bold><italic>crt</italic><sup>-/-</sup> cells were transfected with a GFP-TR&#945; expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (<italic>n</italic> = 8). <italic>White arrowheads</italic> indicate bleached nuclei. DIC images were taken to delineate cell borders and a fluorescence recovery graph indicating relative shuttling of GFP-TR&#945; was generated. <italic>Bar</italic>, 10 &#956;m.</p>
###xml 9 382 9 369 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><bold>TR</bold>&#945; <bold>requires CRT for nuclear export.</bold><italic>crt</italic><sup>-/-</sup> cells were transfected with a GFP-TR&#945; expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (<italic>n</italic> = 8). <italic>White arrowheads</italic> indicate bleached nuclei. DIC images were taken to delineate cell borders and a fluorescence recovery graph indicating relative shuttling of GFP-TR&#945; was generated. <italic>Bar</italic>, 10 &#956;m.</p></caption>
###xml 382 382 369 369 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330002"/>
###xml 0 382 0 369 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="40"><bold>TR</bold>&#945; <bold>requires CRT for nuclear export.</bold><italic>crt</italic><sup>-/-</sup> cells were transfected with a GFP-TR&#945; expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (<italic>n</italic> = 8). <italic>White arrowheads</italic> indicate bleached nuclei. DIC images were taken to delineate cell borders and a fluorescence recovery graph indicating relative shuttling of GFP-TR&#945; was generated. <italic>Bar</italic>, 10 &#956;m.</p></caption><graphic xlink:href="zbc0410850330002"/></fig>
FIGURE 2.TRalpha requires CRT for nuclear export.crt-/- cells were transfected with a GFP-TRalpha expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (n = 8). White arrowheads indicate bleached nuclei. DIC images were taken to delineate cell borders and a fluorescence recovery graph indicating relative shuttling of GFP-TRalpha was generated. Bar, 10 mum.
###end p 39
###begin p 40
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TR</bold>
###xml 8 40 4 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">requires CRT for nuclear export.</bold>
###xml 40 43 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 43 46 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 168 169 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 176 192 168 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White arrowheads</italic>
###xml 361 364 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
TRalpha requires CRT for nuclear export.crt-/- cells were transfected with a GFP-TRalpha expression plasmid and nucleocytoplasmic shuttling was monitored through FRAP (n = 8). White arrowheads indicate bleached nuclei. DIC images were taken to delineate cell borders and a fluorescence recovery graph indicating relative shuttling of GFP-TRalpha was generated. Bar, 10 mum.
###end p 40
###begin p 41
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 9 66 9 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The CRM1-mediated nuclear export pathway is active in <italic>crt</italic></bold>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></bold>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 69 75 69 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">cells.</bold>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 252 268 252 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White arrowheads</italic>
###xml 296 299 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 9 308 9 307 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><bold>The CRM1-mediated nuclear export pathway is active in <italic>crt</italic></bold><sup>-</sup><bold><sup>/</sup></bold><sup>-</sup><bold>cells.</bold> An expression plasmid for a CRM1-dependent shuttling control protein (GFP-GST-NES-NLS) was transfected into <italic>crt</italic><sup>-/-</sup> cells and nucleocytoplasmic shuttling was monitored by FRAP. <italic>White arrowheads</italic> represent bleached nuclei. <italic>Bar</italic>, 10 &#956;m.</p>
###xml 9 308 9 307 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><bold>The CRM1-mediated nuclear export pathway is active in <italic>crt</italic></bold><sup>-</sup><bold><sup>/</sup></bold><sup>-</sup><bold>cells.</bold> An expression plasmid for a CRM1-dependent shuttling control protein (GFP-GST-NES-NLS) was transfected into <italic>crt</italic><sup>-/-</sup> cells and nucleocytoplasmic shuttling was monitored by FRAP. <italic>White arrowheads</italic> represent bleached nuclei. <italic>Bar</italic>, 10 &#956;m.</p></caption>
###xml 308 308 307 307 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330003"/>
###xml 0 308 0 307 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="42"><bold>The CRM1-mediated nuclear export pathway is active in <italic>crt</italic></bold><sup>-</sup><bold><sup>/</sup></bold><sup>-</sup><bold>cells.</bold> An expression plasmid for a CRM1-dependent shuttling control protein (GFP-GST-NES-NLS) was transfected into <italic>crt</italic><sup>-/-</sup> cells and nucleocytoplasmic shuttling was monitored by FRAP. <italic>White arrowheads</italic> represent bleached nuclei. <italic>Bar</italic>, 10 &#956;m.</p></caption><graphic xlink:href="zbc0410850330003"/></fig>
FIGURE 3.The CRM1-mediated nuclear export pathway is active in crt-/-cells. An expression plasmid for a CRM1-dependent shuttling control protein (GFP-GST-NES-NLS) was transfected into crt-/- cells and nucleocytoplasmic shuttling was monitored by FRAP. White arrowheads represent bleached nuclei. Bar, 10 mum.
###end p 41
###begin p 42
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The CRM1-mediated nuclear export pathway is active in <italic>crt</italic></bold>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></bold>
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 60 66 60 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">cells.</bold>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 243 259 243 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White arrowheads</italic>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
The CRM1-mediated nuclear export pathway is active in crt-/-cells. An expression plasmid for a CRM1-dependent shuttling control protein (GFP-GST-NES-NLS) was transfected into crt-/- cells and nucleocytoplasmic shuttling was monitored by FRAP. White arrowheads represent bleached nuclei. Bar, 10 mum.
###end p 42
###begin p 43
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
To ensure that any recovery in GFP signal to bleached nuclei occurred as a result of nucleocytoplasmic shuttling and not as a result of de novo protein synthesis, all experiments were performed in the presence of cycloheximide. DIC microscopy was also performed to visualize monokaryon borders, thereby confirming that the experiments in which no shuttling was observed were conducted in cells that were, indeed, multinucleated as opposed to adjacent independent cells.
###end p 43
###begin p 44
###xml 311 312 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 642 649 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Taken together, these data show that TRalpha nuclear export is LMB-sensitive, suggesting that in live, unfused cells the CRM1 pathway plays a role in mediating export of TRalpha. One possible explanation for these unexpected results is that the heterokaryon system used previously to assay for CRM1 dependence (1) creates an artificial environment in which the effects of deactivating CRM1 activity are overshadowed by cell fusion-dependent up-regulation of alternative export factors such as CRT. With this possibility in mind, we sought to determine whether CRT is used as an alternative, or cooperative, nuclear export receptor by TRalpha in vivo.
###end p 44
###begin p 45
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TR</italic>
###xml 8 74 4 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shuttling Is Inhibited in Living Cells Deficient in CRT Expression</italic>
###xml 174 175 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 177 179 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 181 183 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 185 187 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 368 371 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 371 374 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 383 385 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 484 490 468 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
TRalpha Shuttling Is Inhibited in Living Cells Deficient in CRT Expression-CRT has previously been shown to function as an exportin for nuclear receptors related to TRalpha (8, 11, 12, 31). To address the question of whether TRalpha export is also mediated by CRT, we transiently transfected mouse embryonic fibroblast cells isolated from CRT knock-out mouse embryos (crt-/- cells) (23) with GFP-TRalpha and monitored FRAP in bleached nuclei of transfected CRT-deficient monokaryons (Fig. 2).
###end p 45
###begin p 46
###xml 102 105 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 105 108 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 387 389 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 445 448 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 448 451 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 588 591 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 591 594 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 668 674 660 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
Prior to analysis of nuclear export, we first assessed the ability of TRalpha to enter the nucleus of crt-/- cells. Although nuclear import of both the tumor suppressor p53 and the transcription factor NF-AT3 are impaired in cells deficient in CRT expression, other shuttling proteins including GR and GATA4 are unchanged in their import properties regardless of whether CRT is present (32). Thus, the altered nuclear import of some proteins in crt-/- cells is a specific effect and is not indicative of a general defect in the import cycle. Nuclear import of TRalpha was not impaired in crt-/- cells, indicating that CRT is not required for its nuclear localization (Fig. 2).
###end p 46
###begin p 47
###xml 39 42 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 42 45 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 163 169 159 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 282 285 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 285 288 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 328 331 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 331 334 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 462 468 452 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 613 616 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 616 619 606 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 819 821 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 884 887 874 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 887 890 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 961 962 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 962 967 952 953 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#189;</sub>
###xml 979 985 965 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
Although TRalpha remained localized to crt-/- cell nuclei prior to FRAP, we observed a striking reduction in its nucleocytoplasmic shuttling after photobleaching (Fig. 2). Indeed, only 14% (+/-2%) fluorescence equilibration from unbleached nuclei to bleached nuclei was seen in the crt-/- cell line. In contrast, HeLa cells and crt+/+ cells not treated with LMB showed 56% (+/-4%) and 88% (+/-2%) fluorescence equilibration with unbleached nuclei, respectively (Fig. 1). To demonstrate that the lack of CRT in these cells was not responsible for any nonspecific action preventing all nucleocytoplasmic shuttling, crt-/- cells were also transfected with a shuttling control construct, pNES-GFP-GST-NLS. The fusion protein localizes to the nucleus at steady state and shuttles via a CRM1-mediated nuclear export pathway (29). As expected, shuttling of this protein was not inhibited in crt-/- cells, indicating that the CRM1 pathway is functional in these cells (t(1/2) < 10 min) (Fig. 3). Taken together, these data support the hypothesis that TRalpha can follow a CRT-mediated nuclear export pathway.
###end p 47
###begin p 48
###xml 0 66 0 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRT Is Localized to the Cytoplasm and Nuclei of Various Cell Types</italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 668 675 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 1206 1207 1203 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1226 1227 1223 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1232 1233 1229 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1218 1233 1215 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>B</italic> and <italic>C</italic></xref>
###xml 1519 1522 1512 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 1522 1525 1515 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1533 1534 1526 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1553 1554 1546 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1559 1560 1552 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1545 1560 1538 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>B</italic> and <italic>C</italic></xref>
###xml 2134 2135 2123 2124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2128 2135 2117 2124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
CRT Is Localized to the Cytoplasm and Nuclei of Various Cell Types-Previously, CRT was believed to reside solely in the ER. Recently, however, increasing numbers of reports have identified small fractions of CRT in both the cytosolic and nuclear compartments of various cell lines in addition to its primary location within the ER (33-35). To assess whether a detectable population of CRT was localized to the nuclei of the cells used in our study, we isolated nuclei by biochemical fractionation. To ensure that the nuclei extracted were free of ER and other cytoplasmic contamination, during the purification process nuclei were monitored by DIC at high resolution (Fig. 4A). Purification steps were repeated until only nuclei that were free of ER and other cytoplasmic debris remained. Proteins were extracted from the cytoplasmic fraction and from the purified nuclei and analyzed by Western blot. Blots were probed simultaneously with anti-CRT and anti-beta tubulin, which was used to normalize the data. When comparing the amount of CRT in purified nuclei to the amount of tubulin, a strictly cytoplasmic protein, we found that the purified nuclei from HeLa cells were significantly enriched in CRT (p < 0.001) (Fig. 4, B and C). In HeLa cells, the ratio between CRT and tubulin increased from 1.7 +/- 0.3 in the cytoplasm to 9.6 +/- 4.2 in the nucleus indicating that the amount of CRT observed in the purified nuclei is not a result of residual cytoplasmic contamination. These results were also significant in crt+/+ cells (p < 0.001) (Fig. 4, B and C). In these cells, the ratio between CRT and tubulin increased from 1.3 +/- 0.1 in the cytoplasm to 2.3 +/- 0.7 in the purified nuclei. Together these data provide further evidence that CRT is present in a small but significant fraction within the nucleus in the cell lines used for our experiments. To further demonstrate that CRT is localized to multiple cellular compartments, we performed indirect immunofluorescence assays. Consistent with the Western blot analysis a small population of nuclear CRT was observed in addition to a more prominent cytoplasmic pool (Fig. 4D).
###end p 48
###begin p 49
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 74 9 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CRT is localized to the cytosol and nuclei of various cell types.</bold>
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 201 211 201 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left panel</italic>
###xml 379 390 379 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right panel</italic>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 549 552 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 552 555 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 656 658 653 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MM</italic>
###xml 691 694 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 694 697 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 784 785 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 895 896 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 903 904 900 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 906 907 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 921 924 918 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 924 927 921 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 935 936 932 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 943 945 940 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 947 948 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 959 969 956 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 998 999 995 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1159 1162 1156 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 9 1171 9 1167 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50"><bold>CRT is localized to the cytosol and nuclei of various cell types.</bold><italic>A</italic>, to ensure that purified nuclei were free of ER and other cytoplasmic contaminants, nuclear fractions were monitored by DIC. <italic>Left panel</italic>, a clump of nuclei with residual ER and cytoplasmic debris; these nuclei were subjected to additional purification steps prior to use (see &#8220;Experimental Procedures&#8221;). <italic>Right panel</italic>, an isolated nucleus free of residual ER and other cytoplasmic contaminants. <italic>B</italic>, proteins extracted from purified nuclei and cytosolic fractions from HeLa and <italic>crt</italic><sup>+/+</sup> cells were analyzed by Western blot, using anti-CRT and anti-&#946; tubulin antibodies. Magic Marker (<italic>MM</italic>) size standard is indicated and <italic>crt</italic><sup>-/-</sup> cells were used as a negative control. A representative blot for HeLa cells is shown. <italic>C</italic>, the ratio of CRT to tubulin increased significantly from cytosolic to nuclear fractions in both HeLa cells (<italic>n</italic> = 12, <sup>*</sup>, <italic>p</italic> &lt; 0.001) and <italic>crt</italic><sup>+/+</sup> cells (<italic>n</italic> = 13, <sup>**</sup>, <italic>p</italic> &lt; 0.001). <italic>Error bars</italic>, 99.9% confidence interval. <italic>D</italic>, HeLa cells incubated for 5 h in the presence or absence of LMB, as indicated, were fixed and labeled with anti-CRT antibodies by indirect immunofluorescence. <italic>Bar</italic>, 10 &#956;m.</p>
###xml 9 1171 9 1167 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="50"><bold>CRT is localized to the cytosol and nuclei of various cell types.</bold><italic>A</italic>, to ensure that purified nuclei were free of ER and other cytoplasmic contaminants, nuclear fractions were monitored by DIC. <italic>Left panel</italic>, a clump of nuclei with residual ER and cytoplasmic debris; these nuclei were subjected to additional purification steps prior to use (see &#8220;Experimental Procedures&#8221;). <italic>Right panel</italic>, an isolated nucleus free of residual ER and other cytoplasmic contaminants. <italic>B</italic>, proteins extracted from purified nuclei and cytosolic fractions from HeLa and <italic>crt</italic><sup>+/+</sup> cells were analyzed by Western blot, using anti-CRT and anti-&#946; tubulin antibodies. Magic Marker (<italic>MM</italic>) size standard is indicated and <italic>crt</italic><sup>-/-</sup> cells were used as a negative control. A representative blot for HeLa cells is shown. <italic>C</italic>, the ratio of CRT to tubulin increased significantly from cytosolic to nuclear fractions in both HeLa cells (<italic>n</italic> = 12, <sup>*</sup>, <italic>p</italic> &lt; 0.001) and <italic>crt</italic><sup>+/+</sup> cells (<italic>n</italic> = 13, <sup>**</sup>, <italic>p</italic> &lt; 0.001). <italic>Error bars</italic>, 99.9% confidence interval. <italic>D</italic>, HeLa cells incubated for 5 h in the presence or absence of LMB, as indicated, were fixed and labeled with anti-CRT antibodies by indirect immunofluorescence. <italic>Bar</italic>, 10 &#956;m.</p></caption>
###xml 1171 1171 1167 1167 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330004"/>
###xml 0 1171 0 1167 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="50"><bold>CRT is localized to the cytosol and nuclei of various cell types.</bold><italic>A</italic>, to ensure that purified nuclei were free of ER and other cytoplasmic contaminants, nuclear fractions were monitored by DIC. <italic>Left panel</italic>, a clump of nuclei with residual ER and cytoplasmic debris; these nuclei were subjected to additional purification steps prior to use (see &#8220;Experimental Procedures&#8221;). <italic>Right panel</italic>, an isolated nucleus free of residual ER and other cytoplasmic contaminants. <italic>B</italic>, proteins extracted from purified nuclei and cytosolic fractions from HeLa and <italic>crt</italic><sup>+/+</sup> cells were analyzed by Western blot, using anti-CRT and anti-&#946; tubulin antibodies. Magic Marker (<italic>MM</italic>) size standard is indicated and <italic>crt</italic><sup>-/-</sup> cells were used as a negative control. A representative blot for HeLa cells is shown. <italic>C</italic>, the ratio of CRT to tubulin increased significantly from cytosolic to nuclear fractions in both HeLa cells (<italic>n</italic> = 12, <sup>*</sup>, <italic>p</italic> &lt; 0.001) and <italic>crt</italic><sup>+/+</sup> cells (<italic>n</italic> = 13, <sup>**</sup>, <italic>p</italic> &lt; 0.001). <italic>Error bars</italic>, 99.9% confidence interval. <italic>D</italic>, HeLa cells incubated for 5 h in the presence or absence of LMB, as indicated, were fixed and labeled with anti-CRT antibodies by indirect immunofluorescence. <italic>Bar</italic>, 10 &#956;m.</p></caption><graphic xlink:href="zbc0410850330004"/></fig>
FIGURE 4.CRT is localized to the cytosol and nuclei of various cell types.A, to ensure that purified nuclei were free of ER and other cytoplasmic contaminants, nuclear fractions were monitored by DIC. Left panel, a clump of nuclei with residual ER and cytoplasmic debris; these nuclei were subjected to additional purification steps prior to use (see "Experimental Procedures"). Right panel, an isolated nucleus free of residual ER and other cytoplasmic contaminants. B, proteins extracted from purified nuclei and cytosolic fractions from HeLa and crt+/+ cells were analyzed by Western blot, using anti-CRT and anti-beta tubulin antibodies. Magic Marker (MM) size standard is indicated and crt-/- cells were used as a negative control. A representative blot for HeLa cells is shown. C, the ratio of CRT to tubulin increased significantly from cytosolic to nuclear fractions in both HeLa cells (n = 12, *, p < 0.001) and crt+/+ cells (n = 13, **, p < 0.001). Error bars, 99.9% confidence interval. D, HeLa cells incubated for 5 h in the presence or absence of LMB, as indicated, were fixed and labeled with anti-CRT antibodies by indirect immunofluorescence. Bar, 10 mum.
###end p 49
###begin p 50
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CRT is localized to the cytosol and nuclei of various cell types.</bold>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 192 202 192 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left panel</italic>
###xml 370 381 370 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right panel</italic>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 540 543 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 647 649 644 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MM</italic>
###xml 682 685 679 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 685 688 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 775 776 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 886 887 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 894 895 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 897 898 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 912 915 909 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 915 918 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 926 927 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 934 936 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 938 939 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 950 960 947 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 989 990 986 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1150 1153 1147 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
CRT is localized to the cytosol and nuclei of various cell types.A, to ensure that purified nuclei were free of ER and other cytoplasmic contaminants, nuclear fractions were monitored by DIC. Left panel, a clump of nuclei with residual ER and cytoplasmic debris; these nuclei were subjected to additional purification steps prior to use (see "Experimental Procedures"). Right panel, an isolated nucleus free of residual ER and other cytoplasmic contaminants. B, proteins extracted from purified nuclei and cytosolic fractions from HeLa and crt+/+ cells were analyzed by Western blot, using anti-CRT and anti-beta tubulin antibodies. Magic Marker (MM) size standard is indicated and crt-/- cells were used as a negative control. A representative blot for HeLa cells is shown. C, the ratio of CRT to tubulin increased significantly from cytosolic to nuclear fractions in both HeLa cells (n = 12, *, p < 0.001) and crt+/+ cells (n = 13, **, p < 0.001). Error bars, 99.9% confidence interval. D, HeLa cells incubated for 5 h in the presence or absence of LMB, as indicated, were fixed and labeled with anti-CRT antibodies by indirect immunofluorescence. Bar, 10 mum.
###end p 50
###begin p 51
###xml 69 75 65 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 497 504 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 630 631 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 624 631 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
TRalpha nuclear export is partially inhibited by treatment with LMB (Fig. 1). This suggests a role for CRM1 in TRalpha shuttling, in addition to that played by CRT, and points to a possible interplay between CRT and CRM1. A direct interaction between CRT and CRM1 could, in theory, induce a shift in CRT toward the nucleus upon treatment with LMB, which would be indicative of CRM1 sequestering CRT in this compartment. To test this, we treated cells with LMB and performed immunostaining for CRT in situ. This treatment did not, however, induce a detectable shift in the subcellular localization of CRT toward the nucleus (Fig. 4D); a comparable population of nuclear CRT was observed in both LMB-treated and untreated cells.
###end p 51
###begin p 52
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 142 9 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TR</bold>
###xml 147 180 143 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) from CRT-deficient cell nuclei.</bold>
###xml 180 183 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 183 186 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 375 385 367 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left panel</italic>
###xml 484 487 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 487 490 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 514 530 502 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white arrowheads</italic>
###xml 532 543 520 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right panel</italic>
###xml 604 607 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 607 610 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 725 728 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 9 737 9 724 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="53"><bold>Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TR</bold>&#945;<bold>) from CRT-deficient cell nuclei.</bold><italic>crt</italic><sup>-/-</sup> cells were transfected with a GFP-TR&#945; expression plasmid. Subsequently, CRT-expressing HeLa cells were plated on the same coverslip and cytoplasmic fusion was performed using 50% PEG. <italic>Left panel</italic>, cells were fixed and GFP-TR&#945; localization was observed by fluorescence microscopy. Nuclei of <italic>crt</italic><sup>-/-</sup> cells are indicated by <italic>white arrowheads</italic>. <italic>Right panel</italic>, HeLa cell nuclei exhibit diffuse Hoechst staining, whereas <italic>crt</italic><sup>-/-</sup> have a speckled appearance. Heterokaryon borders are visualized by staining of F-actin with rhodamine-phalloidin. <italic>Bar</italic>, 10 &#956;m.</p>
###xml 9 737 9 724 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="53"><bold>Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TR</bold>&#945;<bold>) from CRT-deficient cell nuclei.</bold><italic>crt</italic><sup>-/-</sup> cells were transfected with a GFP-TR&#945; expression plasmid. Subsequently, CRT-expressing HeLa cells were plated on the same coverslip and cytoplasmic fusion was performed using 50% PEG. <italic>Left panel</italic>, cells were fixed and GFP-TR&#945; localization was observed by fluorescence microscopy. Nuclei of <italic>crt</italic><sup>-/-</sup> cells are indicated by <italic>white arrowheads</italic>. <italic>Right panel</italic>, HeLa cell nuclei exhibit diffuse Hoechst staining, whereas <italic>crt</italic><sup>-/-</sup> have a speckled appearance. Heterokaryon borders are visualized by staining of F-actin with rhodamine-phalloidin. <italic>Bar</italic>, 10 &#956;m.</p></caption>
###xml 737 737 724 724 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330005"/>
###xml 0 737 0 724 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="53"><bold>Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TR</bold>&#945;<bold>) from CRT-deficient cell nuclei.</bold><italic>crt</italic><sup>-/-</sup> cells were transfected with a GFP-TR&#945; expression plasmid. Subsequently, CRT-expressing HeLa cells were plated on the same coverslip and cytoplasmic fusion was performed using 50% PEG. <italic>Left panel</italic>, cells were fixed and GFP-TR&#945; localization was observed by fluorescence microscopy. Nuclei of <italic>crt</italic><sup>-/-</sup> cells are indicated by <italic>white arrowheads</italic>. <italic>Right panel</italic>, HeLa cell nuclei exhibit diffuse Hoechst staining, whereas <italic>crt</italic><sup>-/-</sup> have a speckled appearance. Heterokaryon borders are visualized by staining of F-actin with rhodamine-phalloidin. <italic>Bar</italic>, 10 &#956;m.</p></caption><graphic xlink:href="zbc0410850330005"/></fig>
FIGURE 5.Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TRalpha) from CRT-deficient cell nuclei.crt-/- cells were transfected with a GFP-TRalpha expression plasmid. Subsequently, CRT-expressing HeLa cells were plated on the same coverslip and cytoplasmic fusion was performed using 50% PEG. Left panel, cells were fixed and GFP-TRalpha localization was observed by fluorescence microscopy. Nuclei of crt-/- cells are indicated by white arrowheads. Right panel, HeLa cell nuclei exhibit diffuse Hoechst staining, whereas crt-/- have a speckled appearance. Heterokaryon borders are visualized by staining of F-actin with rhodamine-phalloidin. Bar, 10 mum.
###end p 52
###begin p 53
###xml 0 133 0 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TR</bold>
###xml 138 171 134 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) from CRT-deficient cell nuclei.</bold>
###xml 171 174 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 174 177 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 366 376 358 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left panel</italic>
###xml 475 478 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 478 481 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 505 521 493 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white arrowheads</italic>
###xml 523 534 511 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right panel</italic>
###xml 595 598 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 598 601 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 716 719 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
Addition of CRT to CRT-deficient cells restores rapid nucleocytoplasmic shuttling and promotes export of thyroid hormone receptor (TRalpha) from CRT-deficient cell nuclei.crt-/- cells were transfected with a GFP-TRalpha expression plasmid. Subsequently, CRT-expressing HeLa cells were plated on the same coverslip and cytoplasmic fusion was performed using 50% PEG. Left panel, cells were fixed and GFP-TRalpha localization was observed by fluorescence microscopy. Nuclei of crt-/- cells are indicated by white arrowheads. Right panel, HeLa cell nuclei exhibit diffuse Hoechst staining, whereas crt-/- have a speckled appearance. Heterokaryon borders are visualized by staining of F-actin with rhodamine-phalloidin. Bar, 10 mum.
###end p 53
###begin p 54
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 55 9 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nuclear export of thyroid hormone receptor (TR</bold>
###xml 60 85 56 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) in permeabilized cells.</bold>
###xml 85 86 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 119 120 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 120 122 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 147 148 139 140 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 353 354 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 354 356 342 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 393 394 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 548 549 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 549 551 529 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 553 554 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 674 675 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 675 677 651 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 679 684 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White</italic>
###xml 738 741 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 743 744 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 768 776 744 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels B</italic>
###xml 778 779 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 779 781 755 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 783 784 759 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 791 795 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, t</italic>
###xml 795 797 771 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 799 801 775 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 804 809 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White</italic>
###xml 821 822 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 828 835 804 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel B</italic>
###xml 840 842 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 848 855 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel C</italic>
###xml 958 961 930 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
###xml 9 970 9 941 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="55"><bold>Nuclear export of thyroid hormone receptor (TR</bold>&#945;<bold>) in permeabilized cells.</bold><italic>A</italic>, GFP-TR&#945; remains nuclear at <italic>t</italic><sub>40</sub> in the presence of 670 n<sc>m</sc> CRT. HeLa cells transfected with a GFP-TR&#945; expression plasmid were digitonin permeabilized, and incubated in an export reaction containing CRT, energy regeneration system, and export buffer alone. At <italic>t</italic><sub>40</sub> no GFP-TR&#945; export was observed. <italic>B</italic>, export reactions containing RRL, energy regeneration system, and export buffer were able to support &gt;80% loss of nuclear fluorescence of GFP-TR&#945; at <italic>t</italic><sub>40</sub>. <italic>C</italic>, export reactions containing both CRT and RRL were able to support &gt;95% loss of nuclear fluorescence of GFP-TR&#945; at <italic>t</italic><sub>40</sub>. <italic>White</italic> values were normalized to 2,000 using IPlab 3.55 for <italic>A-C</italic>. <italic>D</italic>, enlarged section from <italic>panels B</italic>, <italic>t</italic><sub>40</sub> (<sup>*</sup>), and <italic>C, t</italic><sub>40</sub> (<sup>**</sup>). <italic>White</italic> values for <sup>*</sup> from <italic>panel B</italic> and <sup>**</sup> from <italic>panel C</italic> were adjusted to 200 for low intensity visualization of the residual GFP-TR&#945; in export reactions. <italic>Bar</italic>, 10 &#956;m.</p>
###xml 9 970 9 941 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="55"><bold>Nuclear export of thyroid hormone receptor (TR</bold>&#945;<bold>) in permeabilized cells.</bold><italic>A</italic>, GFP-TR&#945; remains nuclear at <italic>t</italic><sub>40</sub> in the presence of 670 n<sc>m</sc> CRT. HeLa cells transfected with a GFP-TR&#945; expression plasmid were digitonin permeabilized, and incubated in an export reaction containing CRT, energy regeneration system, and export buffer alone. At <italic>t</italic><sub>40</sub> no GFP-TR&#945; export was observed. <italic>B</italic>, export reactions containing RRL, energy regeneration system, and export buffer were able to support &gt;80% loss of nuclear fluorescence of GFP-TR&#945; at <italic>t</italic><sub>40</sub>. <italic>C</italic>, export reactions containing both CRT and RRL were able to support &gt;95% loss of nuclear fluorescence of GFP-TR&#945; at <italic>t</italic><sub>40</sub>. <italic>White</italic> values were normalized to 2,000 using IPlab 3.55 for <italic>A-C</italic>. <italic>D</italic>, enlarged section from <italic>panels B</italic>, <italic>t</italic><sub>40</sub> (<sup>*</sup>), and <italic>C, t</italic><sub>40</sub> (<sup>**</sup>). <italic>White</italic> values for <sup>*</sup> from <italic>panel B</italic> and <sup>**</sup> from <italic>panel C</italic> were adjusted to 200 for low intensity visualization of the residual GFP-TR&#945; in export reactions. <italic>Bar</italic>, 10 &#956;m.</p></caption>
###xml 970 970 941 941 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330006"/>
###xml 0 970 0 941 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="55"><bold>Nuclear export of thyroid hormone receptor (TR</bold>&#945;<bold>) in permeabilized cells.</bold><italic>A</italic>, GFP-TR&#945; remains nuclear at <italic>t</italic><sub>40</sub> in the presence of 670 n<sc>m</sc> CRT. HeLa cells transfected with a GFP-TR&#945; expression plasmid were digitonin permeabilized, and incubated in an export reaction containing CRT, energy regeneration system, and export buffer alone. At <italic>t</italic><sub>40</sub> no GFP-TR&#945; export was observed. <italic>B</italic>, export reactions containing RRL, energy regeneration system, and export buffer were able to support &gt;80% loss of nuclear fluorescence of GFP-TR&#945; at <italic>t</italic><sub>40</sub>. <italic>C</italic>, export reactions containing both CRT and RRL were able to support &gt;95% loss of nuclear fluorescence of GFP-TR&#945; at <italic>t</italic><sub>40</sub>. <italic>White</italic> values were normalized to 2,000 using IPlab 3.55 for <italic>A-C</italic>. <italic>D</italic>, enlarged section from <italic>panels B</italic>, <italic>t</italic><sub>40</sub> (<sup>*</sup>), and <italic>C, t</italic><sub>40</sub> (<sup>**</sup>). <italic>White</italic> values for <sup>*</sup> from <italic>panel B</italic> and <sup>**</sup> from <italic>panel C</italic> were adjusted to 200 for low intensity visualization of the residual GFP-TR&#945; in export reactions. <italic>Bar</italic>, 10 &#956;m.</p></caption><graphic xlink:href="zbc0410850330006"/></fig>
FIGURE 6.Nuclear export of thyroid hormone receptor (TRalpha) in permeabilized cells.A, GFP-TRalpha remains nuclear at t40 in the presence of 670 nm CRT. HeLa cells transfected with a GFP-TRalpha expression plasmid were digitonin permeabilized, and incubated in an export reaction containing CRT, energy regeneration system, and export buffer alone. At t40 no GFP-TRalpha export was observed. B, export reactions containing RRL, energy regeneration system, and export buffer were able to support >80% loss of nuclear fluorescence of GFP-TRalpha at t40. C, export reactions containing both CRT and RRL were able to support >95% loss of nuclear fluorescence of GFP-TRalpha at t40. White values were normalized to 2,000 using IPlab 3.55 for A-C. D, enlarged section from panels B, t40 (*), and C, t40 (**). White values for * from panel B and ** from panel C were adjusted to 200 for low intensity visualization of the residual GFP-TRalpha in export reactions. Bar, 10 mum.
###end p 54
###begin p 55
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nuclear export of thyroid hormone receptor (TR</bold>
###xml 51 76 47 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) in permeabilized cells.</bold>
###xml 76 77 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 110 111 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 111 113 103 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 138 139 130 131 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 344 345 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 345 347 333 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 384 385 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 539 540 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 540 542 520 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 544 545 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 665 666 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 666 668 642 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 670 675 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White</italic>
###xml 729 732 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 734 735 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 759 767 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels B</italic>
###xml 769 770 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 770 772 746 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 774 775 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 782 786 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, t</italic>
###xml 786 788 762 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 790 792 766 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 795 800 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White</italic>
###xml 812 813 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 819 826 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel B</italic>
###xml 831 833 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 839 846 815 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel C</italic>
###xml 949 952 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar</italic>
Nuclear export of thyroid hormone receptor (TRalpha) in permeabilized cells.A, GFP-TRalpha remains nuclear at t40 in the presence of 670 nm CRT. HeLa cells transfected with a GFP-TRalpha expression plasmid were digitonin permeabilized, and incubated in an export reaction containing CRT, energy regeneration system, and export buffer alone. At t40 no GFP-TRalpha export was observed. B, export reactions containing RRL, energy regeneration system, and export buffer were able to support >80% loss of nuclear fluorescence of GFP-TRalpha at t40. C, export reactions containing both CRT and RRL were able to support >95% loss of nuclear fluorescence of GFP-TRalpha at t40. White values were normalized to 2,000 using IPlab 3.55 for A-C. D, enlarged section from panels B, t40 (*), and C, t40 (**). White values for * from panel B and ** from panel C were adjusted to 200 for low intensity visualization of the residual GFP-TRalpha in export reactions. Bar, 10 mum.
###end p 55
###begin p 56
###xml 0 62 0 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polyethylene Glycol-induced Heterokaryon Formation Restores TR</italic>
###xml 68 105 64 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Export from CRT-deficient Cell Nuclei</italic>
###xml 162 165 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 165 168 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 176 182 168 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 303 306 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 306 309 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 480 482 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 624 627 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 627 630 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 897 904 877 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 1008 1011 984 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 1011 1014 987 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1122 1128 1098 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
Polyethylene Glycol-induced Heterokaryon Formation Restores TRalpha Export from CRT-deficient Cell Nuclei-Having shown that TRalpha nuclear export is impaired in crt-/- cells (Fig. 2), we sought to test whether TRalpha export could be restored by the addition of exogenous CRT. To do so, we transfected crt-/- cells with GFP-TRalpha and then fused them with untransfected HeLa cells. Because PEG-induced heterokaryon formation causes a transient elevation in cellular CRT levels (29), we hypothesized that if TRalpha uses CRT for nuclear export that the fusion process with CRT-expressing HeLa cells would restore export in crt-/- cells. This could occur either as a result of CRT release from the HeLa cell ER or, alternatively, from the relatively low CRT levels present within HeLa cell nuclei and cytosol prior to fusion. Experiments were performed in the presence of cycloheximide to inhibit de novo protein synthesis. Consistent with our prediction, we found that TRalpha was capable of exporting from crt-/- nuclei into the shared cytosol and subsequently reimporting into HeLa nuclei in these heterokaryon assays (Fig. 5). Taken together, the results from these heterokaryon experiments and our live-cell FRAP experiments support the hypothesis that TRalpha uses CRT as a nuclear export receptor.
###end p 56
###begin p 57
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Efficient Nuclear Export of TR</italic>
###xml 36 83 32 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in Permeabilized Cells Requires Cytosol and CRT</italic>
###xml 196 204 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 804 805 780 781 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 813 814 788 789 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 889 890 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 883 890 854 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
Efficient Nuclear Export of TRalpha in Permeabilized Cells Requires Cytosol and CRT-To provide further evidence for a role of CRT in the nuclear export of TRalpha, we performed permeabilized cell in vitro nuclear export assays utilizing purified recombinant GST-CRT. For this assay, HeLa cells were transiently transfected with a GFP-TRalpha expression plasmid. GFP-TRalpha displays a complete and strong nuclear fluorescence 16 h post-transfection. At this point the outer cell membrane was permeabilized with digitonin and export reactions were performed. First, we sought to assess whether exogenous CRT was sufficient to induce nuclear export of TRalpha. Our results showed no observable change in TRalpha nuclear localization between 0 and 40 min irrespective of varying CRT concentration from 270 nm to 1 mum. During this period, all TRalpha remained localized to the nucleus (Fig. 6A).
###end p 57
###begin p 58
###xml 381 383 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 434 435 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 435 436 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 478 479 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 479 481 471 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">40</sub>
###xml 605 606 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 606 607 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 645 646 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 651 652 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 637 652 625 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>B</italic> and <italic>D</italic></xref>
###xml 948 949 932 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 954 955 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 940 955 924 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>C</italic> and <italic>D</italic></xref>
To determine whether additional factors were required to either permit nuclear import of CRT or to aid in the nuclear export of TRalpha in conjunction with CRT, export reactions containing CRT and a cytosol mixture (RRL) alone or a combination of CRT and RRL were similarly assayed at 0 and 40 min. RRL is commonly used as a source of cytosol for nuclear import and export assays (36). Initially, we tested RRL alone. As expected, at t0 TRalpha was localized to the nucleus. At t40 a moderate level of export was observed as indicated by a decrease in GFP-TRalpha fluorescence in the nuclei compared with t0 (>80% loss of fluorescence) (Fig. 6, B and D). Upon addition of RRL and CRT in combination, however, we observed a striking increase in the nuclear export of TRalpha as compared with that which was observed for RRL or CRT individually. Indeed, over a similar time course nuclear export was nearly complete (>95% fluorescence loss) (Fig. 6, C and D). These data suggest that an additional factor (or factors) present in the cytosol interacts cooperatively with CRT to mediate efficient nuclear export of TRalpha.
###end p 58
###begin p 59
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 39 9 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RRL contains CRM1 but not CRT.</bold>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MM</italic>
###xml 9 216 9 216 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="60"><bold>RRL contains CRM1 but not CRT.</bold> HeLa whole cell extract and varying volumes of RRL were subject to Western blot analysis, using anti-CRM1 and anti-CRT antibodies. Magic Marker (<italic>MM</italic>) size standard is indicated.</p>
###xml 9 216 9 216 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="60"><bold>RRL contains CRM1 but not CRT.</bold> HeLa whole cell extract and varying volumes of RRL were subject to Western blot analysis, using anti-CRM1 and anti-CRT antibodies. Magic Marker (<italic>MM</italic>) size standard is indicated.</p></caption>
###xml 216 216 216 216 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330007"/>
###xml 0 216 0 216 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="60"><bold>RRL contains CRM1 but not CRT.</bold> HeLa whole cell extract and varying volumes of RRL were subject to Western blot analysis, using anti-CRM1 and anti-CRT antibodies. Magic Marker (<italic>MM</italic>) size standard is indicated.</p></caption><graphic xlink:href="zbc0410850330007"/></fig>
FIGURE 7.RRL contains CRM1 but not CRT. HeLa whole cell extract and varying volumes of RRL were subject to Western blot analysis, using anti-CRM1 and anti-CRT antibodies. Magic Marker (MM) size standard is indicated.
###end p 59
###begin p 60
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RRL contains CRM1 but not CRT.</bold>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MM</italic>
RRL contains CRM1 but not CRT. HeLa whole cell extract and varying volumes of RRL were subject to Western blot analysis, using anti-CRM1 and anti-CRT antibodies. Magic Marker (MM) size standard is indicated.
###end p 60
###begin p 61
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 835 836 830 831 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
The GTPase Ran plays an integral role in the shuttling of many transcription factors and exists predominantly in a GTP-bound state within the nucleus. In this conformation, RanGTP participates in the formation of export complexes containing the classical leucine-rich NES (3, 4, 37, 38). In addition, it also stabilizes protein kinase inhibitor/CRT interactions as well as enhances CRT-dependent nuclear export of protein kinase inhibitor in permeabilized cells (12). It has been shown in permeabilized cell nuclear export assays that residual nuclear RanGTP remaining in cells after permeabilization was sufficient to permit CRT-dependent nuclear export (12). To determine the role of Ran in the nuclear export of TRalpha, we performed assays with recombinant CRT in the absence of RanGTP or having supplemented the system with 1.9 mum RanGTP. We did not, however, observe any difference in TRalpha nuclear localization between these conditions; TRalpha remained localized to the nucleus in either case (data not shown). This suggests that RanGTP is not the limiting factor for TRalpha nuclear export.
###end p 61
###begin p 62
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 327 329 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 473 481 473 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 546 547 546 547 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 550 552 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 748 750 740 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Several factors may play a role in stabilizing CRT/cargo interactions, inducing a conformational shift in CRT, or in other nonspecific functions. Calcium, for example, modulates CRT conformation within the lumen of the ER (39) and also regulates CRT function as a chaperone for the T-cell protein perforin (40). In addition, Ca2+ enhances CRT-mediated nuclear export of GR-GFP but, interestingly, excess Ca2+ also inhibits classical NES-regulated nuclear export of Rev-GFP in vitro (15). We supplemented permeabilized cell export assays with 20 mm Ca2+ in the presence of CRT but observed no difference in TRalpha nuclear localization. Under these conditions TRalpha remained localized to the nucleus (data not shown). These results suggest that Ca2+ also is not the limiting factor required for nuclear export in these assays.
###end p 62
###begin p 63
###xml 102 108 98 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 417 423 413 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 556 564 548 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Based on our findings in live cells that the nuclear export of TRalpha shows partial CRM1 dependence (Fig. 1), we performed Western blot analysis to test whether CRM1 was present in RRL and could be the additional factor required for efficient CRT-dependent nuclear export. Our data show that CRM1 was present in RRL and HeLa cell extracts, whereas CRT was detected only in HeLa cell extract and was absent from RRL (Fig. 7). These findings point to the possibility that CRM1 could be the additional factor accounting for the enhanced export of TRalpha in in vitro export assays supplemented with RRL. A cooperative interaction between CRT and CRM1, whether direct or indirect, also accounts for the observation that TRalpha is not exported as efficiently from nuclei treated with RRL, as CRT is absent from this exogenous cytosol replacement.
###end p 63
###begin p 64
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TR</italic>
###xml 8 35 4 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Interacts Directly with CRT</italic>
###xml 184 190 176 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 263 264 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 257 264 245 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 290 291 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 284 291 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 309 310 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 303 310 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>C</italic></xref>
###xml 440 441 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 434 441 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 443 449 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 482 483 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 476 483 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 485 491 469 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 570 571 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 564 571 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 573 579 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 629 630 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 623 630 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 632 638 616 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 673 674 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 667 674 647 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>C</italic></xref>
###xml 676 682 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 699 707 679 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 812 815 792 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 815 818 795 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 824 827 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 827 830 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 954 961 930 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
TRalpha Interacts Directly with CRT-To determine whether interactions between TRalpha, CRT, and CRM1 during nuclear export are direct or indirect, GST pull-down assays were performed (Fig. 8). A GST-CRT fusion protein was incubated with His-tagged TRalpha (Fig. 8A), His-tagged CRM1 (Fig. 8B), or both (Fig. 8C), and the input (flow-through) and binding (elution) fractions were analyzed by SDS-PAGE. TRalpha interacted with GST-CRT (Fig. 8A, lane 3), but not with GST alone (Fig. 8A, lane 5). In contrast, all input CRM1 was present in the flow-through fraction (Fig. 8B, lane 5); no CRM1 bound specifically to CRT alone (Fig. 8B, lane 6), or together with TRalpha (Fig. 8C, lane 4). Supplementing in vitro binding assays with RRL had no effect on complex formation (data not shown). Complex formation in HeLa, crt+/+, and crt-/- cells was not detectable by coimmunoprecipitation assays (data not shown), suggesting that interaction of TRalpha with CRT in situ is transient and that only a small fraction of TRalpha forms export complexes at any given time. This is consistent with the primarily nuclear population of TR at steady state.
###end p 64
###begin title 65
DISCUSSION
###end title 65
###begin p 66
###xml 159 166 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 185 193 181 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 558 564 542 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 722 725 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 725 728 709 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
Here, we present findings that provide evidence for a previously uncharacterized mechanism for the dynamic shuttling of TRalpha. We have used a combination of in vivo FRAP experiments, in vitro digitonin-permeabilized cell nuclear export assays of transiently transfected cells, and GST pull-down assays to investigate aspects of TRalpha subcellular trafficking. Taken together, our data suggest a novel export mechanism in which CRT directly binds TRalpha, and CRT and CRM1 work cooperatively to promote rapid, efficient export of TRalpha from the nucleus (Fig. 9). Alternatively, when the CRM1 pathway is blocked or CRT levels are increased under cellular stress, CRT can act independently as a less efficient exportin. crt-/- cell lines fail to support nuclear export of TRalpha, suggesting that CRT is indispensable for TRalpha nuclear export. Thus, CRT may be the most important component of the TRalpha nuclear export pathway. These data suggest that CRT deficiency prevents CRM1 interacting either directly or indirectly with TRalpha, and inhibits both cooperative and autonomous TRalpha export as a consequence.
###end p 66
###begin p 67
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 1054 1056 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 520 524 <span type="species:ncbi:4530">rice</span>
Prior to this study, the role that CRT plays in nuclear export was a subject of debate. Previously, CRT was thought to reside permanently within the ER lumen where it participates in the maturation of newly synthesized proteins and sequesters Ca2+. In addition to its prominence in the ER, however, increasing numbers of reports have suggested that CRT may in fact be present in small fractions in other cellular compartments. For example, CRT appears to interact with a ubiquitin-like nuclear protein in the nucleus of rice cells (34). Moreover, CRT also localizes to the nuclear matrix of some carcinoma cells and assists in chromatin formation (35). All of these data suggest that CRT is likely to possess an evolutionarily conserved ability to access the nucleus, where it appears to serve multiple functions. Recently, a mechanism involving the post-translational processing and retrotranslocation of CRT from the ER to the cytoplasm has been identified, suggesting a potential pathway for CRT to subsequently gain access to the nucleus via import (41).
###end p 67
###begin p 68
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 37 9 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Thyroid hormone receptor (TR</bold>
###xml 42 72 38 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) interacts directly with CRT.</bold>
###xml 72 80 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 141 142 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 195 201 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 280 286 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 298 304 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 394 401 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 406 407 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 433 442 417 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 6-8</italic>
###xml 471 472 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 521 527 505 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 573 579 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 591 597 575 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 674 681 658 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 686 687 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 712 717 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">input</italic>
###xml 720 726 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 765 774 749 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7-9</italic>
###xml 803 804 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1017 1023 985 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 1113 1119 1077 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 1131 1137 1095 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 1227 1234 1191 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 1239 1240 1203 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 1277 1284 1237 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 1289 1290 1249 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 1324 1334 1284 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 8-10</italic>
###xml 9 1470 9 1430 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="69"><bold>Thyroid hormone receptor (TR</bold>&#945;<bold>) interacts directly with CRT.</bold><italic>In vitro</italic> binding interactions were examined by GST pull-down assays. <italic>A</italic>, His-TR&#945; (46 kDa) was retained by GST-CRT bait (<italic>lane 3</italic>, elution), whereas the negative control GST-only bait did not retain TR&#945; (<italic>lane 5</italic>, elution). <italic>Lane 1</italic>, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); <italic>lanes 2</italic> and <italic>4</italic>, TR&#945; protein inputs; <italic>lanes 6-8</italic>, reference protein samples. <italic>B</italic>, CRM1 alone was not retained on either GST-CRT (<italic>lane 3</italic>, elution) or negative control GST-only bait (<italic>lane 6</italic>, elution). <italic>Lane 1</italic>, Bio-Rad Kaleidoscope protein molecular mass standards, given in kDa (KPS); <italic>lanes 2</italic> and <italic>5</italic>, His-CRM1 flow-through (<italic>input</italic>); <italic>lane 4</italic>, no prey input, GST-CRT bait elution; <italic>lanes 7-9</italic>, reference protein samples. <italic>C</italic>, TR&#945; binds CRT, but His-CRM1 does not interact directly with the TR&#945;-CRT complex. His-TR&#945; was retained by GST-CRT bait from the combined TR&#945;:His-CRM1 input, whereas the His-CRM1 was not retained (<italic>lane 4</italic>, elution). The negative control GST-only bait did not retain either TR&#945; or His-CRM1 (<italic>lane 7</italic>, elution). <italic>Lane 1</italic>, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); <italic>lanes 2</italic> and <italic>5</italic>, His-tagged TR&#945; and CRM1 input; <italic>lanes 3</italic> and <italic>6</italic>, post-prey binding wash samples; <italic>lanes 8-10</italic>, reference protein samples. The His-CRM1 input included full-length CRM1 and lower molecular weight degradation products, as indicated.</p>
###xml 9 1470 9 1430 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="69"><bold>Thyroid hormone receptor (TR</bold>&#945;<bold>) interacts directly with CRT.</bold><italic>In vitro</italic> binding interactions were examined by GST pull-down assays. <italic>A</italic>, His-TR&#945; (46 kDa) was retained by GST-CRT bait (<italic>lane 3</italic>, elution), whereas the negative control GST-only bait did not retain TR&#945; (<italic>lane 5</italic>, elution). <italic>Lane 1</italic>, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); <italic>lanes 2</italic> and <italic>4</italic>, TR&#945; protein inputs; <italic>lanes 6-8</italic>, reference protein samples. <italic>B</italic>, CRM1 alone was not retained on either GST-CRT (<italic>lane 3</italic>, elution) or negative control GST-only bait (<italic>lane 6</italic>, elution). <italic>Lane 1</italic>, Bio-Rad Kaleidoscope protein molecular mass standards, given in kDa (KPS); <italic>lanes 2</italic> and <italic>5</italic>, His-CRM1 flow-through (<italic>input</italic>); <italic>lane 4</italic>, no prey input, GST-CRT bait elution; <italic>lanes 7-9</italic>, reference protein samples. <italic>C</italic>, TR&#945; binds CRT, but His-CRM1 does not interact directly with the TR&#945;-CRT complex. His-TR&#945; was retained by GST-CRT bait from the combined TR&#945;:His-CRM1 input, whereas the His-CRM1 was not retained (<italic>lane 4</italic>, elution). The negative control GST-only bait did not retain either TR&#945; or His-CRM1 (<italic>lane 7</italic>, elution). <italic>Lane 1</italic>, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); <italic>lanes 2</italic> and <italic>5</italic>, His-tagged TR&#945; and CRM1 input; <italic>lanes 3</italic> and <italic>6</italic>, post-prey binding wash samples; <italic>lanes 8-10</italic>, reference protein samples. The His-CRM1 input included full-length CRM1 and lower molecular weight degradation products, as indicated.</p></caption>
###xml 1470 1470 1430 1430 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330008"/>
###xml 0 1470 0 1430 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="69"><bold>Thyroid hormone receptor (TR</bold>&#945;<bold>) interacts directly with CRT.</bold><italic>In vitro</italic> binding interactions were examined by GST pull-down assays. <italic>A</italic>, His-TR&#945; (46 kDa) was retained by GST-CRT bait (<italic>lane 3</italic>, elution), whereas the negative control GST-only bait did not retain TR&#945; (<italic>lane 5</italic>, elution). <italic>Lane 1</italic>, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); <italic>lanes 2</italic> and <italic>4</italic>, TR&#945; protein inputs; <italic>lanes 6-8</italic>, reference protein samples. <italic>B</italic>, CRM1 alone was not retained on either GST-CRT (<italic>lane 3</italic>, elution) or negative control GST-only bait (<italic>lane 6</italic>, elution). <italic>Lane 1</italic>, Bio-Rad Kaleidoscope protein molecular mass standards, given in kDa (KPS); <italic>lanes 2</italic> and <italic>5</italic>, His-CRM1 flow-through (<italic>input</italic>); <italic>lane 4</italic>, no prey input, GST-CRT bait elution; <italic>lanes 7-9</italic>, reference protein samples. <italic>C</italic>, TR&#945; binds CRT, but His-CRM1 does not interact directly with the TR&#945;-CRT complex. His-TR&#945; was retained by GST-CRT bait from the combined TR&#945;:His-CRM1 input, whereas the His-CRM1 was not retained (<italic>lane 4</italic>, elution). The negative control GST-only bait did not retain either TR&#945; or His-CRM1 (<italic>lane 7</italic>, elution). <italic>Lane 1</italic>, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); <italic>lanes 2</italic> and <italic>5</italic>, His-tagged TR&#945; and CRM1 input; <italic>lanes 3</italic> and <italic>6</italic>, post-prey binding wash samples; <italic>lanes 8-10</italic>, reference protein samples. The His-CRM1 input included full-length CRM1 and lower molecular weight degradation products, as indicated.</p></caption><graphic xlink:href="zbc0410850330008"/></fig>
FIGURE 8.Thyroid hormone receptor (TRalpha) interacts directly with CRT.In vitro binding interactions were examined by GST pull-down assays. A, His-TRalpha (46 kDa) was retained by GST-CRT bait (lane 3, elution), whereas the negative control GST-only bait did not retain TRalpha (lane 5, elution). Lane 1, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); lanes 2 and 4, TRalpha protein inputs; lanes 6-8, reference protein samples. B, CRM1 alone was not retained on either GST-CRT (lane 3, elution) or negative control GST-only bait (lane 6, elution). Lane 1, Bio-Rad Kaleidoscope protein molecular mass standards, given in kDa (KPS); lanes 2 and 5, His-CRM1 flow-through (input); lane 4, no prey input, GST-CRT bait elution; lanes 7-9, reference protein samples. C, TRalpha binds CRT, but His-CRM1 does not interact directly with the TRalpha-CRT complex. His-TRalpha was retained by GST-CRT bait from the combined TRalpha:His-CRM1 input, whereas the His-CRM1 was not retained (lane 4, elution). The negative control GST-only bait did not retain either TRalpha or His-CRM1 (lane 7, elution). Lane 1, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); lanes 2 and 5, His-tagged TRalpha and CRM1 input; lanes 3 and 6, post-prey binding wash samples; lanes 8-10, reference protein samples. The His-CRM1 input included full-length CRM1 and lower molecular weight degradation products, as indicated.
###end p 68
###begin p 69
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Thyroid hormone receptor (TR</bold>
###xml 33 63 29 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) interacts directly with CRT.</bold>
###xml 63 71 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 132 133 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 186 192 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 271 277 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 289 295 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 385 392 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 397 398 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 424 433 408 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 6-8</italic>
###xml 462 463 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 512 518 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 564 570 548 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 582 588 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 665 672 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 677 678 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 703 708 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">input</italic>
###xml 711 717 695 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 756 765 740 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7-9</italic>
###xml 794 795 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1008 1014 976 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 1104 1110 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 1122 1128 1086 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lane 1</italic>
###xml 1218 1225 1182 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 1230 1231 1194 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 1268 1275 1228 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 1280 1281 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 1315 1325 1275 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 8-10</italic>
Thyroid hormone receptor (TRalpha) interacts directly with CRT.In vitro binding interactions were examined by GST pull-down assays. A, His-TRalpha (46 kDa) was retained by GST-CRT bait (lane 3, elution), whereas the negative control GST-only bait did not retain TRalpha (lane 5, elution). Lane 1, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); lanes 2 and 4, TRalpha protein inputs; lanes 6-8, reference protein samples. B, CRM1 alone was not retained on either GST-CRT (lane 3, elution) or negative control GST-only bait (lane 6, elution). Lane 1, Bio-Rad Kaleidoscope protein molecular mass standards, given in kDa (KPS); lanes 2 and 5, His-CRM1 flow-through (input); lane 4, no prey input, GST-CRT bait elution; lanes 7-9, reference protein samples. C, TRalpha binds CRT, but His-CRM1 does not interact directly with the TRalpha-CRT complex. His-TRalpha was retained by GST-CRT bait from the combined TRalpha:His-CRM1 input, whereas the His-CRM1 was not retained (lane 4, elution). The negative control GST-only bait did not retain either TRalpha or His-CRM1 (lane 7, elution). Lane 1, Bio-Rad prestained Kaleidoscope protein molecular mass standards, given in kDa (P-KPS); lanes 2 and 5, His-tagged TRalpha and CRM1 input; lanes 3 and 6, post-prey binding wash samples; lanes 8-10, reference protein samples. The His-CRM1 input included full-length CRM1 and lower molecular weight degradation products, as indicated.
###end p 69
###begin p 70
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 9.</label>
###xml 9 65 9 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model for nuclear export of thyroid hormone receptor (TR</bold>
###xml 70 126 66 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) involving a cooperative CRT and CRM1-mediated pathway.</bold>
###xml 126 127 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 183 186 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 186 189 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 315 341 311 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">double-headed curved arrow</italic>
###xml 412 423 404 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dashed line</italic>
###xml 539 540 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 611 614 595 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 614 617 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 725 726 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 967 973 943 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D, crt</italic>
###xml 973 976 949 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 9 1116 9 1088 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="71"><bold>Model for nuclear export of thyroid hormone receptor (TR</bold>&#945;<bold>) involving a cooperative CRT and CRM1-mediated pathway.</bold><italic>A</italic>, nuclear export complex in cells expressing CRT (HeLa, <italic>crt</italic><sup>+/+</sup>) in which CRT binding promotes a cooperative export pathway involving CRM1. This cooperative interaction is indicated by the <italic>double-headed curved arrow</italic>. CRM1 binding to TR&#945; may require additional factors (indicated by <italic>dashed line</italic>). Although CRT levels are low under these conditions, export of TR&#945; is efficient and rapid export is observed. <italic>B</italic>, inefficient nuclear export of TR&#945; in cells expressing CRT (HeLa, <italic>crt</italic><sup>+/+</sup>) occurs upon treatment with LMB. CRM1 is inactivated but CRT can still support modest export autonomously. <italic>C</italic>, rapid export of TR&#945; occurs even in the presence of LMB upon PEG-induced heterokaryon fusion. Although the CRM1 pathway is inactivated, transient CRT release from the ER renders sufficient CRT levels to support rapid export of TR&#945;. <italic>D, crt</italic><sup>-/-</sup> cells do not support nuclear export of TR&#945; because CRT is not present to facilitate the CRM1-dependent component of the export pathway.</p>
###xml 9 1116 9 1088 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="71"><bold>Model for nuclear export of thyroid hormone receptor (TR</bold>&#945;<bold>) involving a cooperative CRT and CRM1-mediated pathway.</bold><italic>A</italic>, nuclear export complex in cells expressing CRT (HeLa, <italic>crt</italic><sup>+/+</sup>) in which CRT binding promotes a cooperative export pathway involving CRM1. This cooperative interaction is indicated by the <italic>double-headed curved arrow</italic>. CRM1 binding to TR&#945; may require additional factors (indicated by <italic>dashed line</italic>). Although CRT levels are low under these conditions, export of TR&#945; is efficient and rapid export is observed. <italic>B</italic>, inefficient nuclear export of TR&#945; in cells expressing CRT (HeLa, <italic>crt</italic><sup>+/+</sup>) occurs upon treatment with LMB. CRM1 is inactivated but CRT can still support modest export autonomously. <italic>C</italic>, rapid export of TR&#945; occurs even in the presence of LMB upon PEG-induced heterokaryon fusion. Although the CRM1 pathway is inactivated, transient CRT release from the ER renders sufficient CRT levels to support rapid export of TR&#945;. <italic>D, crt</italic><sup>-/-</sup> cells do not support nuclear export of TR&#945; because CRT is not present to facilitate the CRM1-dependent component of the export pathway.</p></caption>
###xml 1116 1116 1088 1088 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0410850330009"/>
###xml 0 1116 0 1088 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig9"><label>FIGURE 9.</label><caption><p textid="71"><bold>Model for nuclear export of thyroid hormone receptor (TR</bold>&#945;<bold>) involving a cooperative CRT and CRM1-mediated pathway.</bold><italic>A</italic>, nuclear export complex in cells expressing CRT (HeLa, <italic>crt</italic><sup>+/+</sup>) in which CRT binding promotes a cooperative export pathway involving CRM1. This cooperative interaction is indicated by the <italic>double-headed curved arrow</italic>. CRM1 binding to TR&#945; may require additional factors (indicated by <italic>dashed line</italic>). Although CRT levels are low under these conditions, export of TR&#945; is efficient and rapid export is observed. <italic>B</italic>, inefficient nuclear export of TR&#945; in cells expressing CRT (HeLa, <italic>crt</italic><sup>+/+</sup>) occurs upon treatment with LMB. CRM1 is inactivated but CRT can still support modest export autonomously. <italic>C</italic>, rapid export of TR&#945; occurs even in the presence of LMB upon PEG-induced heterokaryon fusion. Although the CRM1 pathway is inactivated, transient CRT release from the ER renders sufficient CRT levels to support rapid export of TR&#945;. <italic>D, crt</italic><sup>-/-</sup> cells do not support nuclear export of TR&#945; because CRT is not present to facilitate the CRM1-dependent component of the export pathway.</p></caption><graphic xlink:href="zbc0410850330009"/></fig>
FIGURE 9.Model for nuclear export of thyroid hormone receptor (TRalpha) involving a cooperative CRT and CRM1-mediated pathway.A, nuclear export complex in cells expressing CRT (HeLa, crt+/+) in which CRT binding promotes a cooperative export pathway involving CRM1. This cooperative interaction is indicated by the double-headed curved arrow. CRM1 binding to TRalpha may require additional factors (indicated by dashed line). Although CRT levels are low under these conditions, export of TRalpha is efficient and rapid export is observed. B, inefficient nuclear export of TRalpha in cells expressing CRT (HeLa, crt+/+) occurs upon treatment with LMB. CRM1 is inactivated but CRT can still support modest export autonomously. C, rapid export of TRalpha occurs even in the presence of LMB upon PEG-induced heterokaryon fusion. Although the CRM1 pathway is inactivated, transient CRT release from the ER renders sufficient CRT levels to support rapid export of TRalpha. D, crt-/- cells do not support nuclear export of TRalpha because CRT is not present to facilitate the CRM1-dependent component of the export pathway.
###end p 70
###begin p 71
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model for nuclear export of thyroid hormone receptor (TR</bold>
###xml 61 117 57 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) involving a cooperative CRT and CRM1-mediated pathway.</bold>
###xml 117 118 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 174 177 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 177 180 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 306 332 302 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">double-headed curved arrow</italic>
###xml 403 414 395 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dashed line</italic>
###xml 530 531 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 602 605 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 605 608 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 716 717 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 958 964 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D, crt</italic>
###xml 964 967 940 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
Model for nuclear export of thyroid hormone receptor (TRalpha) involving a cooperative CRT and CRM1-mediated pathway.A, nuclear export complex in cells expressing CRT (HeLa, crt+/+) in which CRT binding promotes a cooperative export pathway involving CRM1. This cooperative interaction is indicated by the double-headed curved arrow. CRM1 binding to TRalpha may require additional factors (indicated by dashed line). Although CRT levels are low under these conditions, export of TRalpha is efficient and rapid export is observed. B, inefficient nuclear export of TRalpha in cells expressing CRT (HeLa, crt+/+) occurs upon treatment with LMB. CRM1 is inactivated but CRT can still support modest export autonomously. C, rapid export of TRalpha occurs even in the presence of LMB upon PEG-induced heterokaryon fusion. Although the CRM1 pathway is inactivated, transient CRT release from the ER renders sufficient CRT levels to support rapid export of TRalpha. D, crt-/- cells do not support nuclear export of TRalpha because CRT is not present to facilitate the CRM1-dependent component of the export pathway.
###end p 71
###begin p 72
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 263 266 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 266 269 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 418 421 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 421 424 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 588 596 576 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 832 839 816 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 862 870 846 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Although low levels of CRT are found in multiple cellular compartments, the majority of CRT present in heterokaryons immediately after cell fusion comes as a result of ER disruption and its release from the ER lumen (29). Although TRalpha export was inhibited in crt-/- monokaryons, rapid shuttling and fluorescence equilibration was observed between nuclei of heterokaryons. For CRT to mediate export of TRalpha from crt-/- nuclei, presumably it must first be imported into these same nuclei. Following import, CRT could then interact with TRalpha and facilitate its nuclear export. Our in vitro nuclear export assays suggest that whereas CRT is necessary for efficient export, there is also an additional factor (or factors) in the cytosol required for its nuclear import, its role in the export of TRalpha, or both. Based on our in vivo FRAP experiments, our in vitro nuclear export assays, and our Western blot analysis of RRL composition, we suggest that at least one of these additional factors is the exportin CRM1.
###end p 72
###begin p 73
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 628 629 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 629 634 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#189;</sub>
###xml 645 648 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 648 651 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 651 652 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 652 657 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#189;</sub>
In both HeLa and crt+/+ cell lines, TRalpha displayed rapid nucleocytoplasmic shuttling in the absence of LMB. Although the precise mechanism by which this export occurs remains to be determined, there are several potential explanations. CRT and CRM1 could undergo a conformational shift that maximizes interaction with components of the nuclear pore complex, thus expediting the export process. Alternatively, CRM1 could increase the affinity of CRT for TRalpha allowing for more efficient export. In any case, the fluorescence equilibration between photobleached and unbleached nuclei in monokaryons of either cell type (HeLa t(1/2) = 40 min, crt+/+t(1/2) = 10 min) indicates that TRalpha shuttles rapidly under these conditions.
###end p 73
###begin p 74
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 364 367 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 367 370 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
As treatment with LMB results in covalent modification of a critical cysteine residue within CRM1 (42), this potential cooperative interaction with CRT may be abolished upon LMB treatment. As such, CRT may still be capable of binding TRalpha and facilitating export, albeit to a lesser extent. This would explain our results in which TRalpha shuttling in HeLa and crt+/+ monokaryons occurs only slowly after treatment with LMB.
###end p 74
###begin p 75
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 208 209 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 211 217 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 490 496 482 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 1238 1244 1226 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
Finally, our model takes into account the cell fusion-dependent release of CRT during heterokaryon experiments (29) and explains the stark contrast between LMB-insensitive TRalpha shuttling in heterokaryons (1) versus LMB-sensitive shuttling in monokaryons (present study). Although CRT may be the limiting factor in TRalpha nuclear export under normal circumstances, this limitation is countered by the increased efficiency of export resulting from the cooperative pathway involving CRM1 (Fig. 9). Although CRM1 is undoubtedly inactivated by LMB treatment in heterokaryons, the attenuated nucleocytoplasmic shuttling expected may not be observed due to the increased cytosolic levels of CRT resulting from PEG-induced cell fusion. Under these conditions, the relatively low levels of CRT found within the nucleus or cytosol under normal circumstances would be markedly increased and its low levels would no longer be limiting. Although, according to this model, autonomous CRT-mediated export of TRalpha is not as efficient as cooperative export in the presence of CRM1, the sheer increase in free CRT directly after cell fusion may be enough to overcome this deficiency and allow rapid nuclear export to proceed in the presence of LMB (Fig. 9).
###end p 75
###begin p 76
###xml 331 333 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 469 470 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 741 749 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 769 776 752 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Previously, the only support for the hypothesis that CRT mediates export of TR was the finding that the DBD of TRbeta is sufficient to confer nuclear export when fused to a GFP reporter. The DBDs of TRbeta and GR share 43% sequence homology and, most importantly, the amino acids predicted to be key for CRT binding are conserved (12). Thus, it is not unreasonable to propose that the TRbeta DBD could also interact directly with CRT, as has been shown for the GR DBD (8). Examining the specific nucleocytoplasmic shuttling properties of TRalpha domains within CRT-deficient and CRT-expressing cell lines will provide valuable insight into the physical basis for TRalpha binding of CRT. Comprehensive analysis of the effects of mutations by in vitro binding assays and in vivo functional assays should help to identify and clarify those specific amino acid sequences required for nuclear export, as well as nuclear import, of TRalpha.
###end p 76
###begin p 77
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 134 136 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 319 320 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 322 324 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 485 487 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 489 491 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 627 629 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 1078 1080 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 1364 1389 1360 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae.</italic>
###xml 1481 1483 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 1484 1486 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1358 1363 <span type="species:ncbi:4932">yeast</span>
###xml 1364 1388 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
In a prior study we showed that in vitro-generated 35S-labeled TRalpha does not interact with purified CRM1 in a His pull-down assay (28). However, most CRM1-dependent NESs bind CRM1 with low affinity and often require additional adapter proteins to serve as a bridge between CRM1 and the cargo protein being exported (3, 43). For example, Ran-binding protein 3 (RanBP3) directly binds CRM1 in the nucleus and increases the affinity of CRM1 for NES containing cargo as well as RanGTP (44, 45). In addition, RanBP3 binding also maximizes the interaction of the CRM1 export complex with nucleoporins of the nuclear pore complex (44). Similar conditions are observed for CRM1 binding of other regulatory proteins that participate in nucleocytoplasmic shuttling. Although steroid receptor coactivator-1 contains two clusters of hydrophobic amino acids similar to the classic leucine-rich NES associated with CRM1-mediated nuclear export, this protein failed to accumulate within the nuclei of COS-7 cells when these regions were mutated even though its export was sensitive to LMB (46). Presumably then, an unknown adapter protein that is recognized by both CRM1 and steroid receptor coactivator-1 accounts for the nuclear accumulation of steroid receptor coactivator-1 upon LMB treatment. Other examples include both the 60 S and 40 S ribosomal subunits of the yeast Saccharomyces cerevisiae. These large complexes undergo CRM1-mediated nuclear export in an adapter-dependent manner (47-49). Such situations are analogous to our TRalpha export pathway model in which additional export factors may be required to facilitate the CRM1-dependent component of TRalpha translocation from the nucleus to cytoplasm.
###end p 77
###begin p 78
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 327 333 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 421 428 421 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 613 615 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 617 619 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 839 840 835 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
The model presented here explains several previously anomalous observations relating to CRT, CRM1, and nuclear receptor export in general. There is certainly a discrepancy between the shuttling kinetics of nuclear receptors in a heterokaryon system versus under other experimental conditions, such as those reported in Walther et al. (29). Particularly striking is the disparity observed between protein shuttling within in vivo monokaryon experiments compared with the interspecies heterokaryon assay. Here, for the first time, the observation that some nuclear receptors such as TRalpha (present study) and GR (50, 51) rely in part on CRM1-dependent nuclear export can be reconciled with the observation that cell lines deficient in CRT expression, but retaining their CRM1 activity, fail to support nuclear export of the same proteins (8) (present study).
###end p 78
###begin p 79
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crt</italic>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn6">5</xref>
###xml 418 426 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 431 438 431 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
Interestingly, we have also shown that the p53 tumor suppressor protein displays highly reduced shuttling kinetics in crt+/+ monokaryons as compared with heterokaryon assays using HeLa and NIH/3T3 cells.5 Although the significance of these observations remain to be determined, they again high-light the complexity of nucleocytoplasmic transport pathways and point to a similar discrepancy between p53 shuttling under in vitro and in vivo conditions. As p53 undergoes nuclear export in a CRM1-dependent manner (52-55), this observation should be considered when designing experiments that attempt to utilize p53 as a control for CRM1 activity.
###end p 79
###begin p 80
###xml 1845 1847 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref56">56</xref>
###xml 1848 1850 1824 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref58">58</xref>
These data provide insight into the nuclear export pathway of TRalpha and suggest a possible mechanism by which other shuttling proteins may use complex and, to some extent, functionally redundant export modes involving both characterized pathways (CRM1) and a multitude of other chaperones. In addition, these results also represent a novel role in nuclear export for the functionally diverse protein CRT. Although more research will be necessary to precisely determine the significance of this cooperative export pathway, regulation of TRalpha target genes may be influenced in several ways. Inefficient TRalpha nuclear export in the absence of CRT could, for example, be indicative of an evolved compensatory mechanism to up-regulate the transcription of genes involved in similar cellular processes as the numerous ones that have been identified for CRT. Conversely, rapid shuttling of TRalpha dependent on an intact cooperative export pathway may be representative of a general mechanism to clear shuttling transcription factors from the nucleus under physiological conditions. This cooperative CRM1/CRT-mediated nuclear export pathway may be relevant to related members of the nuclear receptor superfamily other than TRalpha. Identification of this export pathway and other mechanisms by which nuclear receptors exit the nucleus will contribute substantially to understanding the regulatory activity of these proteins. One challenge for the future will be to examine how regulation of this cellular compartmentalization is impaired or altered in the case of aberrant nuclear receptor expression. In addition, defining how nuclear export integrates TRalpha activity with other signaling pathways may provide important clues as to the mode of action of mutant TRs that are responsible for a host of pathological conditions including cancer (56-58).
###end p 80
###begin p 81
###xml 381 382 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 428 432 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 434 449 <span type="species:ncbi:10633">simian virus 40</span>
###xml 497 503 <span type="species:ncbi:9986">rabbit</span>
The abbreviations used are: TRalpha, thyroid hormone receptor alpha;TRbeta, thyroid hormone receptor beta; LMB, leptomycin B; FRAP, fluorescence recovery after photobleaching; CRT, calreticulin; NLS, nuclear localization signal; NES, nuclear export signal; GR, glucocorticoid receptor; DBD, DNA binding domain; ER, endoplasmic reticulum; PEG, polyethylene glycol; GST, glutathione S-transferase; GFP, green fluorescent protein; SV40, simian virus 40; DIC, differential interference contrast; RRL, rabbit reticulocyte lysate; RanBP3, Ran-binding protein 3; MEM, minimal essential medium; PBS, phosphate-buffered saline.
###end p 81
###begin p 82
M. E. Grespin and L. A. Allison, unpublished results.
###end p 82

